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Mammalian orthoreoviruses (reoviruses) induce apoptosis in vitro and in vivo. 
The capacity to induce apoptosis differs among strains of reovirus, and in infected L-
cells the Type 3 Dearing (T3D) strain induces apoptosis to a greater extent than the 
Type 1 Lang (T1L) strain. Studies utilizing reassortant viruses mapped the capacity to 
induce apoptosis to the M2 genome segment which encodes the outer capsid protein 
µ1.  Here, I describe a strain difference in the subcellular distribution of µ1 in 
reovirus-infected cells.  Using a panel of reassortant viruses, I mapped this difference 
in distribution of µ1 in infected cells to the M2 genome segment. 
 In vitro studies have shown that in HEK 293 reovirus-infected cells, the 
extrinsic apoptotic pathway is activated with subsequent activation of the intrinsic 
apoptotic pathway.  Here, I describe the optimization of flow cytometric protocols to 
monitor activation of apoptotic pathways in cells and to detect expression of µ1 in 
transiently transfected cells.  Using these protocols, I was able to evaluate cytochrome 
c release from mitochondria, activation of caspases, and permeabilization of the 
cellular membrane in cells expressing µ1.  My data indicates that µ1 induces apoptosis 
by activating the intrinsic and extrinsic apoptotic pathways. However, inhibition of 
caspase activation does not prevent cytochrome c release in µ1-expressing cells. 
Additionally, I found that caspase activation influences the steady-state levels of µ1.  I 
also found that µ1 expression permeabilized the plasma membrane, yet the 
 mitochondrial membrane potential remains intact.  To better understand the capacity 
of µ1 to permeabilize membranes, I utilized Bax-/-Bak-/- double knockout mouse 
embryonic fibroblasts.  Infection with reovirus strain T3DN caused release of 
cytochrome c from mitochondria in the double knockout cells. Also, expression of µ1 
in double knockout cells resulted in cytochrome c release from the mitochondria. My 
data confirm the capacity of µ1 to induce apoptosis when expressed in cells and 
addresses the apoptotic pathways and cellular changes that are a consequence of µ1 
expression.  This study lends further support that µ1 is the reovirus protein responsible 
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Programmed Cell Death 
 
 Three types of programmed cell death have been described and are 
differentiated largely by the morphology of the dying cell: apoptosis (type I), 
autophagy (type II), and necrosis (type III). Autophagy is characterized by the 
formation of large double-membrane vacuoles inside the cell that enclose portions of 
the cytoplasm, cytosolic proteins, or organelles [reviewed in (31, 33)].  The contents 
of autophagic vacuoles are degraded when these structures fuse with lysosomes. 
Studies have shown that autophagy occurs in different species, including nematodes 
(C. elegans), fruit flies (D. melanogaster), and mammals (mouse and human cell 
lines), and is linked to various genes in these organisms. Autophagy serves multiple 
roles such as physiological development, degradation of intracellular pathogens, and 
processing aged organelles. Additionally, the macromolecules which result from 
autophagy are released back into the cytoplasm to be reused in metabolism [reviewed 
in (33)]. The current hypothesis of the role of autophagy in programmed cell death 
suggest that cells enter autophagy as a means of coping with extreme environmental 
stress; however, when this survival mechanism fails the cell undergoes programmed 
cell death [reviewed in (31)]. 
 Necrosis is distinguished by certain cell morphologies including an increase in 
cytoplasmic volume, organelle breakdown, and rupture of the plasma membrane.  The 
lysis of the cell, and consequential leakage of the cytoplasmic contents into the 
extracellular space, promotes a pro-inflammatory response in the organism. 
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Classically, necrosis has been described as sudden cell death that proceeds without a 
described program; however, current data indicate that activation of specific signaling 
pathways can induce a cell to undergo necrosis [reviewed in (31)]. In contrast to 
necrosis, apoptosis is the classical method of programmed cell death. Apoptosis is 
essential for normal embryogenesis and tissue homeostasis and is distinct from 
necrosis as it does not promote inflammation with subsequent damage to surrounding 
cells. Cells undergoing apoptosis display characteristic morphological changes 
including: chromatin condensation, nuclear fragmentation, plasma membrane 
blebbing, and cell shrinkage. In addition, exposure of phosphatidylserine on the 
external leaflet of the plasma membrane acts to signal professional phagocytic cells to 
ingest the apoptotic cells and remove them from the tissue. [reviewed in (52)]. 
However, in the absence of phagocytosis, late stage apoptotic cells enter a necrotic 
stage termed secondary necrosis (38). The morphological changes associated with 
apoptosis are orchestrated by activation of intracellular enzymes that break down the 




The mechanisms by which cells undergo apoptosis are essential knowledge for 
describing the role of apoptosis in pathogenesis, tumorgenesis, and infections. Early 
investigations into the normal loss of specific cells during development in the 
nematode Caenorhabditis elegans (C. elegans) identified two genes (ced-3 and ced-4) 
that were essential for apoptosis of these cells. In order to induce apoptosis, the CED-3 
zymogen had to be processed by CED-4. Further investigations found that CED-3 is a 
homolog of the mammalian interleukin-1β-converting enzyme (ICE). ICE is a cysteine 
protease that specifically cleaves polypeptides after aspartate residues and was the first 
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protein to be called a caspase (cysteinyl aspartate-specific proteinase or caspase-1) 
[reviewed in (48, 59)]. To date, fourteen mammalian caspases have been recognized; 
not all of these enzymes are involved in apoptosis (51).   
All caspases have a similar 3-domain structure: an NH2-terminal domain (N-
peptide), a large subunit, and a small subunit. Caspases are activated by proteolytic 
processing; the proenzyme is cleaved into a large and a small subunit that remain 
associated and fold to form a catalytic site. Active caspase-1 and caspase-3 have been 
purified and shown to exist as tetramers consisting of two small and two large subunits 
with two catalytically active sites. Caspases are characterized by their N-peptide 
domains, or prodomains. Those that have long prodomains are initiator caspases. 
Initiator caspases have either a death effector domain (DED) or caspase associated 
recruitment domain (CARD), both of which consist of six α-helices, in their 
prodomain. The CARD and DED motifs promote protein-protein interactions that are 
important for recruitment and activation of initiator caspases by multimeric protein 
complexes. It is thought that initiator caspases are activated autocatalytically as a 
consequence of increased local concentrations following their recruitment by adapter 
molecules. Caspases with short prodomains are called effector caspases and are 
activated following proteolytic cleavage by initiator caspases. Effector caspases cleave 
and activate cellular substrates responsible for the morphological changes associated 
with apoptosis [reviewed in (54)]. 
 
Activation of the extrinsic and intrinsic apoptotic pathways 
 
There are two major cellular locations where proapoptotic signals are 
integrated—the plasma membrane and the mitochondria. Integration at the plasma 
membrane leads activation of the extrinsic apoptotic pathway and integration at the 
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mitochondria leads to activation of the intrinsic apoptotic pathway. The extrinsic 
apoptotic pathway is activated at the plasma membrane by binding of a ligand to a 
death receptor. Death receptors are a sub-family of the tumor necrosis factor (TNF)-
receptor superfamily and include Fas/APO-1 (CD95) and death receptors 4 and 5 
(DR4 and DR5); they bind ligands such as Fas ligand or TNF-related apoptosis 
inducing ligand (TRAIL). Each death receptor has an intracellular domain, called the 
death domain (DD), that oligomerizes upon ligand interaction. Oligomerized death 
receptors recruit adapter proteins, such as FADD/Mort1, that have both a DD (C-
terminus) and a death effector domain (DED) (N-terminus). Procaspase-8 is recruited 
to the adaptor protein FADD through interaction of a DED in the prodomain region of 
procaspase-8 with a DED at the N-terminus of FADD. Formation of this complex of 
death receptors, adapter proteins, and procaspase-8, called the Death Inducing 
Signaling Complex (DISC), results in the autocatalytic cleavage of the prodomain of 
procaspase-8 and the formation of activated caspase-8 dimers. Activated caspase-8 is 
an initiator caspase that can cleave and activate effector caspases such as caspase-3. 
Activation of caspase-8 can be inhibited by cellular (c-FLIP) or viral (v-FLIP) proteins 
containing DED compete with procaspase-8 for binding sites on the adapter molecules 
[reviewed in (61) and (Fig. 1.1)]. 
 The intrinsic apoptotic pathway is activated by mitochondrial outer membrane 
permeabilization (MOMP). Bax and Bak are pro-apoptotic proteins in the Bcl-2 family 
that oligomerize and cause pore formation in the outer mitochondrial membrane. 
MOMP results in release of cytochrome c and other proapoptotic molecules from the 
mitochondrial intermembrane space. Cytoplasmic cytochrome c binds to the 
mammalian homologue of CED-4, Apaf-1, which is found as a heptamer in a wagon-
wheel-like formation. The ‘Hub’ of the Apaf-1 heptamer is comprised of the N-
terminus of the Apaf-1 proteins and contains the CARDs. An ‘Arm’ region of each 
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Apaf-1 peptide extends out from the ‘Hub’ ending in a ‘Spoke’ region. Cytochrome c 
binds to the ‘Spoke’ region forming the protein complex known as the apoptosome 
and mediating a conformational change that exposes the CARDs of Apaf-1. Pro-
caspase-9, which contains a CARD in its N-peptide region, is activated by binding to 
the apoptosome via the CARD on Apaf-1. However, the exact mechanism of pro-
caspase-9 cleavage remains unknown. Activated caspase-9 can subsequently cleave 
and activate effector caspases such as caspase-3 [reviewed in (3) and (Fig. 1.1)]. 
 Activation of the extrinsic and intrinsic apoptotic pathways both lead to 
activation of effector caspases, caspase-3 and -7. A small percentage of caspase-3 
knockout mice are viable with notable developmental defects related to increased cell 
survival. A consistent observation in cells devoid of caspase-3 is the inability to 
condense chromatin and fragment DNA during apoptosis. This occurs because 
ICAD/DFF-45, the inhibitor of the endonuclease CAD, is a substrate of activated 
caspase-3; however ICAD/DFF-45 knockout mice do not display the developmental 
anomalies associated with the caspase-3 knockout mice. This implies that 
endonucleases have redundant rolls or that CAD activity is not essential for apoptosis. 
Furthermore,  activated caspase-3 processes the substrates α-fodrin and gelsolin 
causing the membrane blebbing morphology associated with apoptosis [reviewed in 
(51)]. Caspase-3 has also been implicated in cleaving proteins responsible for DNA 
repair (such as PARP), pre-mRNA splicing, sterol biosynthesis, and Rho-GTPase 
activity [reviewed in (48)].
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Figure 1.1. Diagram illustrating programmed cell death by activation of the intrinsic 
and extrinsic apoptotic pathways. The intrinsic apoptotic pathway is activated by 
cellular stress, such as UV-irradiation and pharmacologically induced toxicity, causing 
oligomerization of Bax and Bak on the outer mitochondrial membrane.  This can be 
blocked by overexpression of Bcl-2. Pore formation in the outer mitochondrial 
membrane causes release of cytochrome c which binds to Apaf-1 allowing CARD 
sites to be available to bind and activate caspase-9.  This can be blocked by cellular 
inhibitors of apoptosis proteins (cIAPs) binding to CARDs preventing caspase-9 from 
binding; however, smac/DIABLO (also released from the mitochondrial 
intermembrane space) can bind cIAPs preventing them from interacting with Apaf-1. 
The extrinsic apoptotic pathway is activated by binding of ligands (TRAIL, FasL, etc.) 
to death receptors (DRs) at the plasma membrane resulting in oligomerization of the 
DRs and recruitment of the adapter protein FADD. Caspase-8 binds to FADD 
resulting in cleavage and activation of caspase-8.  Cleavage of caspase-8 is prevented 
by c-FLIPs binding to FADD instead of caspase-8. Activated caspase-8 can activate 
Bid by cleaving it to tBid.  tBid can activate the intrinsic apoptotic pathway by causing 
oligomerization of Bax and Bak . Activated caspase-8 and activated caspase-9 can 
cleave caspase-3 which acts as an effector caspase by cleaving cellular substrates.
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Bcl-2 protein family 
 
 Studies in C. elegans uncovered another gene, ced-9, that is important for 
apoptosis regulation. Overexpression of the ced-9 gene product prevented apoptosis, 
and subsequently a mammalian homologue to this gene, the bcl-2 oncogene, was 
indentified [reviewed in (22)]. The Bcl-2 family of proteins, encompassing both pro-
apoptotic and anti-apoptotic members, are defined by a shared homology of conserved 
domains (BH1-4 domains). The anti-apoptotic Bcle-2 family members are 
homologous at each of the four domains whereas the pro-apoptotic Bcl-2 proteins are 
conserved at BH1-3 or BH3-only. Two pro-apoptotic members, Bax and Bak 
oligomerize and insert into the mitochondrial outer membrane resulting in pore 
formation and MOMP [reviewed in (36)]. Pro-apoptotic Bcl-2 proteins, tBid and Bim, 
are implicated in the direct activation of Bax and Bak (13). tBid is formed after 
cleavage of Bid by activated caspase-8, linking the activation of the extrinsic apoptotic 
pathway to the activation of the intrinsic apoptotic pathway [Fig. 1.1 and (39)]. The 
anti-apoptotic Bcl-2 proteins (including Bcl-2, Bcl-xL, Bcl-w, A1, and Mcl-1) interact 
with tBid and Bim, preventing them from activating Bax and Bak. Other pro-apoptotic 
members, such as Bad, Bik, and Noxa, prevent the anti-apoptotic Bcl-2 proteins from 
sequestering tBid and Bim (13, 36). Activated pro-apoptotic Bcl-2 members can also 
bind the anti-apoptotic members putting the cell in a ‘sensitized’ state; so that any 
other activation of pro-apoptotic members would result in activation of Bax and Bak 
(13). 
The regulation of Bax and Bak is important as illustrated by the lack of effect 
that multiple death-inducing agents have on Bax /Bak double-knockout mouse 
embryonic fibroblasts (62). Both Bax and Bak exist as monomers in non-apoptotic 
cells, with Bak being localized at the mitochondrial outer membrane and Bax in the 
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cytoplasm or loosely associated with the mitochondria [reviewed in (22)]. Once 
activated, Bax localizes to the mitochondria and forms small complexes at the outer 
mitochondrial membrane. This translocation and oligomerization is associated with 
the release of cytochrome c from the mitochondrial intermembrane space as well as 
the loss of  mitochondrial membrane potential (64). Bak also forms complexes at the 
outer mitochondrial membrane that are associated with cytochrome c and 
mitochondria membrane potential loss. Additionally, heterooligomeric complexes of 
Bax and Bak can form on the outer mitochondrial membrane. These complexes can be 
comprised of Bax, Bak, or both Bax and Bak (64). 
 
The role of intracellular organelles in apoptosis 
 
Mitochondria are the organelles responsible for activating the intrinsic 
apoptotic pathway which can be initiated by members of the Bcl-2 family of proteins 
(39). However, the primary function of mitochondria is to generate ATP. In doing so, 
a proton gradient is maintained across the inner mitochondrial membrane generating a 
resting membrane potential called the mitochondrial membrane potential (ΔΨm) (2). 
ΔΨm is regulated by the permeability transition pore (PT-pore) comprising several 
proteins including a voltage-dependent anion channel (VDAC) responsible for the 
transport of small molecules across the outer mitochondrial membrane, and an 
adenine-nucleotide-translocator (ANT) at the inner mitochondrial membrane 
responsible for ATP/ADP exchange. Studies have shown that oxidative stress and an 
increase in calcium levels can lead to a prolonged opening of the PT-pore with 
subsequent loss of ΔΨm. The failure to generate ATP, the formation of reactive 
oxygen intermediates, and the influx of water caused expansion of the inner 
mitochondrial membrane and the rupture of the outer mitochondrial membrane. Bcl-2  
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proteins also seem to be able to regulate this apoptotic event as it has been shown that 
Bax activation leads to a loss of ΔΨm whereas overexpression of Bcl-2 can inhibit the 
loss of ΔΨm  (34).   
Another organelle involved in caspase activation is the endoplasmic reticulum 
(ER). ER stress can lead to the activation of the intrinsic apoptotic pathway, via ER 
signaling upstream of the mitochondria. Tunicamycin, an inhibitor of N-glycosylation 
in the ER, and thapsigargin, an inhibitor of Ca2+-ATPase, induce caspase-3 activation 
in wild-type mouse embryonic fibroblasts but fail to do so in Bax/Bak double-
knockout mouse embryonic fibroblasts (62). Another pathway initiated by the ER 
stress response (including the unfolded protein response) is activation of c-Jun N-
terminal kinase (JNK) which leads to the phosphorylation of Bim and the subsequent 
activation of Bax and the intrinsic apoptotic pathway (43). Additionally, caspase-12 
has been associated with ER-stress induced apoptosis in murine cells. In this case, 
activated caspase-7 translocates from the ER and activates caspase-12. Caspase-12 has 
been shown to activate caspase-9 without involvement of the mitochondria [reviewed 
in (14)]. Additionally, a BH-3 only Bcl-2 protein, Bik, has been associated with the 
activation of caspase-12 (63) and an anti-apoptotic Bcl-2 protein, Bcl-xL, was shown 
to protect cells from ER-stress induced apoptosis (56). Also, calpains, Ca+2-dependent 
cysteine proteases (21), have been implicated in activating caspase-12 as a result of 
Ca+2 efflux from the ER (44). Furthermore, an isoform of caspase-8, caspase-8L, has 
been reported to be recruited and activated at the ER (5). However, there continues to 
be conflicting evidence as to whether the ER-stress response constitutes another 
apoptotic pathway or if it relies on the mitochondria-initiated intrinsic apoptotic 




 Nonfusogenic mammalian orthoreoviruses (reoviruses) belong to the family 
Reoviridae and the genus Orthoreovirus. The non-enveloped virion is comprised of 
two icosohedral protein coats: an outer capsid with a T=13 subunit arrangement and 
an inner capsid or core with a T=1 lattice, surrounding 10 double-stranded RNA 
(dsRNA) genome segments. The genome segments are divided into three groups and 
numbered according to size (large segments (L) 1-3, medium segments (M) 1-3, and 
small segments (S) 1-4). All genome segments encode one protein except for segments 
M3 and S1 which encode two proteins via second initiator codon sites. The outer 
capsid consists of three viral proteins: µ1 encoded by M2, σ1 encoded by S1, and σ3 
encoded by S4. The inner capsid contains five proteins: λ2 encoded by L2;  λ1 
encoded by L3, λ3 encoded by L1, µ2 encoded by M1, and σ2 encoded by S2 (55). 
 
Summary of reovirus life-cycle 
 
 In order to infect a cell, reoviruses bind to junctional adhesion molecule A 
(JAM A) on the cell surface via the outer capsid protein σ1 (4). Reoviruses also bind 
sialic acid and β1 integrins through interactions with σ1 and λ2, respectively (32, 42). 
Entry into the cell occurs by clathrin-mediated endocytosis. Shortly thereafter, the 
virus is trafficked into endo/lysosomes where outer capsid protein σ3 is degraded 
exposing the outer capsid protein µ1. Proteolytic processing of µ1 produces an 
‘intermediate sub-virion particle’ (ISVP) (28, 55). Like virions, ISVPs are infectious 
but are not transcriptionally active; however ISVPs unlike intact virions indicating that 
they may be able to enter the cell directly by penetrating the plasma membrane. The 
outer capsid protein µ1, present on the ISVP, undergoes a conformational change that 
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leads to the permeabilization of the plasma membrane or facilitates the release of the 
digested viron from the endo/lysosome.Once released into the cytoplasm, the  outer 
capsid proteins µ1 and σ1 dissociate from the core (11). The exact mechanism by 
which the particle exits the endo/lysosome and at which point the core particle 
becomes transcriptionally active is unknown (55). 
 The core particle contains the viral RNA-dependent RNA-polymerase, λ3, and 
is responsible for primary transcription of the viral genome to produce viral mRNAs. 
The viral transcripts are capped by the viral capping enzyme activity associated with 
the λ2 viral protein, and then are extruded through the five-fold vertices of the core 
particle (55). Viral core particles, newly synthesized viral proteins, and viral mRNAs 
are localized to inclusion bodies, termed viral factories, that are largely comprised of 
the nonstructural viral protein µNS (6, 7). The mechanism for assortment of the 
single-stranded RNAs (ssRNAs) and formation of fully-intact double layered virions 
remains unknown. The nonstructural protein σNS has been implicated in (+)-strand 
RNA assortment and packaging due to its capacity to bind ssRNAs. Using the (+)-
strand RNA as a template, the complementary (-)-strand RNA is generated to form a 
dsRNA genome segment. Expression of core proteins in cells results in the formation 
of core-like particles, and outer capsid proteins µ1 and σ3 have been shown to self-
assemble into heterohexamers (55). Furthermore, core particles incubated with 
purified µ1:σ3 complexes become recoated with µ1 and σ3 and biochemically and 
morphologically resemble virions (12). 
 Little is known about the egress of virons from the host cell after the reovirus 
replication cycle. Budding or trafficking of virions from the host cell has not been 
described. Currently, it is thought that apoptosis or lysis of the host cell results in 
release and spread of the virus (55).   
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 Reoviruses can infect different mammalian hosts and many different cell types. 
The prototype viruses used in laboratory research were isolated from humans, either 
from the respiratory or enteric tract. Epidemiological studies have shown that most 
adults are seropositive for reovirus antibodies. Despite being ubiquitous, reoviruses 
have yet to be definitively linked to known pathological conditions in the human 
population. However, they continue to be researched as a model for viral assembly and 
viral-induced apoptosis in newborn and neonatal mice resulting in myocardial, 
neuronal, and hepatocyte injury. Additionally, reoviruses are currently being 




 The capacity of reoviruses to induce apoptosis in vivo and in vitro is well 
documented (49). In the 1970s, two research groups observed that normal human, 
primate, and mouse cells did not support reovirus infections, whereas cell lines that 
had been transformed with an oncogene which were permissive to infection. In these 
studies, the permissive cells underwent apoptosis as a result of reovirus infection (30, 
35). Furthermore, murine cell lines that express epidermal growth factor (EGF) 
receptor or that can use this signaling pathway (e.g. constitutively activated Son-of-
Sevenless (SOS) or Ras proteins) support reovirus infections and are susceptible to 
reovirus-induced apoptosis (58). During infection, these cells fail to phosphorylate 
dsRNA-activated protein kinase (PKR) whereas cells lacking the EGF receptor 
signaling pathway phosphorylated PKR and were resistant to infection (57). There are 
conflicting results that describe the inability of the virus to replicate in non-permissive 
cell lines. Strong et al. published data indicating viral transcripts are made but not 
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translated; however, Alain et al. found that reovirus virons were unable to disassemble 
(1, 57). 
 Neonatal mice are susceptible to encephalitis and myocarditis as a result of 
reovirus-induced apoptosis. Studies in vivo and in vitro, in primary and immortal 
mouse cell lines, show increased levels of caspase-3 activation, DNA laddering, and 
TUNEL staining (terminal deoxynucleotidyl transferase-mediated dUTP nick end-
labeling) in reovirus infected cells as well as bystander cells. Intracerebral inoculation 
of reovirus results in apoptosis in infected and nearby neurons causing irrecoverable 
central nervous system damage and death. Currently, it is believed that bystander cells 
undergo apoptosis through the paracrine interaction of a soluble death ligand released 
from infected cells. Intramuscular inoculation of reovirus results in apoptosis of 
cardiac myocytes associated with viral infection. The extent of apoptosis can be 
reduced in both the CNS and myocytes by broad-spectrum caspase inhibitors, 
providing evidence that cellular damage is apoptosis-mediated (25, 26, 53).   
In order to induce apoptosis, virus must bind to the cell, be internalized, and 
undergo proteolytic processing. Preventing acidification or cathepsin protease activity 
in endosomes blocks apoptosis in infected cells. However, this block can be 
circumvented by infecting cells with ISVPs that were generated by incubating purified 
virions with chymotrypsin (19). This finding indicated that proteolytic processing of 
the outer capsid is important for apoptosis induction; however inhibiting viral 
transcription/translation has no affect on the ability of the virus to induce apoptosis at 
high multiplicities of infection (MOI). Supporting data showed that UV-irradiated 
replication incompetent virus could induce apoptosis, albeit at a high MOI (16, 60). 
Also, previous work has shown that NF-κB activation (20) and calpain activation (27) 
are required for reovirus-induced apoptosis, though the mechanisms of their 
activations and contributions is largely unresolved. 
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Mechanism of reovirus-induced apoptosis 
 
Reovirus infection induces apoptosis by stimulating release of tumor necrosis 
factor (TNF)-related apoptosis-inducing ligand (TRAIL) from infected cells, and the 
upregulation of death receptors 4 and 5 (DR4, DR5) expression on the cell membrane. 
TRAIL, binding to the DR4 and DR5, activates the extrinsic apoptotic pathway 
resulting in the cleavage of caspase-8 (15). Activated caspase-8 then cleaves the 
protein Bid (39) activating the intrinsic apoptotic pathway through Bax and Bak 
permeabilization of the outer mitochondrial membrane. Cytochrome c and 
smac/DIABLO are released from the mitochondrial intermembrane space during 
reovirus-induced apoptosis (37). smac/DIABLO binds to multiple cellular inhibitors of 
apoptosis proteins (cIAPs) and prevents their inhibition of caspase activation (29, 41). 
However, the extent of protection offered by the cIAPs has been called into question 
and the physiologically relevant inhibitor, XIAP, is antagonized by multiple proteins 
including smac/DIABLO (8, 41). The end result is reovirus-induced apoptosis, 
initiated by activation of the extrinsic and intrinsic apoptotic pathways, and executed 
by the downstream targets of activated effector caspases-3 (15). 
 Reoviruses induce apoptosis in mouse fibroblast L929 cells. Furthermore, the 
Type 3 Dearing (T3D) strain induces significantly higher levels of apoptosis in 
comparison to the Type 1 Lang (T1L) strain. Using reassortant genetics, the capacity 
to induce apoptosis was attributed to two genes encoding outer capsid proteins: S1 
encoding the σ1 and σ1s proteins, and M2 encoding the μ1 protein. However, studies 
using HeLa cells found the S1 gene segment to be the only genetic determinant for 
apoptosis induction in that cell line (18). A recent publication refuted the necessity of 
σ1 to induce apoptosis in infected Chinese hamster ovary (CHO) cells. Danthi et al. 
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bypassed the binding of σ1 to the cell receptor by facilitating antibody-mediated 
uptake of the virus. Using a panel of reassortant viruses, they mapped the ability of 




During infection, or when expressed simultaneously, µ1 associates with outer 
capsid protein σ3 to form a heterohexameric complex (40). The full length protein 
consists of 708 amino acids (76 kD) and has a myristoyl group at the covalently linked 
to the second glycine reside at the N-terminus. As stated above, μ1 undergoes 
proteolytic cleavage during viral disassembly that is necessary for escape of the virus 
from the endosome. The putative autocleavage at amino acid 42, occurs during the 
assembly of µ1-σ3 heterohexamers (40) or during viral uncoating (46), yielding a 
myristoylated N-terminal fragment µ1N (1-41) and µ1C (43-708), both of which 
remain particle associated  (55). Cleavage at the C-terminus occurs in vivo in the 
intestine or the cellular endosomes and  in vitro by trypsin or chymotrypsin to generate 
µ1δ (1-582) or δ (43-582), and the C-terminal fragment φ (583-708) (45).The (582-
708)/φ region contains three separate amphipathic α-helices spanning residues 582-
675 [Fig. 1.2 and (17)].   
The N-terminal myristoyl group of µ1 is necessary for inciting virion escape 
from the endo/lysosome by membrane penetration (47). The N-terminal cleavage of 
µ1 to µ1N and µ1C is necessary for hemolytic activity and permeabilization of 
cellular membranes to facilitate core particle entry into the cytoplasm (50). However, 
the C-terminal cleavage to form µ1δ/δ and φ is dispensable for cell entry and 
activation of the transcriptase in cell culture. Currently, the biological significance of 
the C-terminal cleavage is unknown (10). In vitro exposure of ISVPs to high 
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concentrations of cesium ions causes µ1 to undergo a conformational change, become 
more hydrophobic, and become sensitive to proteases. This conformational change is 
associated with the capacity of the ISVP to lyse red blood cells (RBC) (9). Core 
particles recoated with µ1 that cannot undergo the conformational change fail to lyse 
RBC or escape from endosomes (11). Also, recombinant reoviruses which contained 
point mutations in the δ region associated with ethanol resistance were unable to 




The Parker laboratory initiated an investigation of µ1 in transiently transfected 
cells and has shown that µ1 can induce apoptosis as measured by caspase-3 activation 
and nuclear changes. Also, µ1 localized to intracellular membranes including 
mitochondria, ER, and lipid droplets. Mapping studies indicate that the φ fragment is 
necessary and sufficient to induce apoptosis and localizes to membranes (17). 
Supported by the mapping studies for apoptosis induction and the membrane 
permeabilization properties of µ1, I hypothesize that µ1, alone or in concert with 
cellular proteins, permeabilizes cellular membranes, during transfection or infection, 
which causes apoptosis. Furthermore, I believe this mechanism to be inherently 
regulated so that apoptosis occurs after viral assembly, resulting in release and spread 






Figure 1.2. Ribbon diagram and illustration of cleavage fragments of µ1. (A) Ribbon 
diagram of µ1 derived from the crystal structure of σ3:µ1 heterohexamer. PDB 
reference is 1jmu. Image was created using PyMOL viewer (DeLano Scientific). 
Colors correspond to (B) illustration of cleavage fragments produced by proteolytic 
processing of µ1 during viral entry and uncoating. The N-terminal fragment (µ1N) is 
shown in light purple, the δ fragment (43-582) is shown in purple and the φ fragment 
(582-708) is shown in red. The C-terminus sequence (675-708), shown in gray, is not 
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EXPRESSION OF REOVIRUS OUTER-CAPSID PROTEIN μ1 LEADS TO 




Mammalian orthoreoviruses induce apoptosis in vivo and in vitro; however, the 
specific mechanism by which apoptosis is induced is not fully understood. Previous 
studies have identified the reovirus M2 gene segment as a determinant for apoptosis 
induction. Furthermore the µ1 protein, encoded by the M2 gene segment, has been 
shown to induce apoptosis and localize to intracellular membranes when expressed in 
cells. Here, I report that expression of µ1 in cells activated both the intrinsic and 
extrinsic apoptotic pathways. I found that similar to reovirus infection, µ1 expression 
alone induced release of cytochrome c and smac/DIABLO from the mitochondrial 
intermembrane space into the cytosol. In addition, expression of µ1 activated the 
initiator caspases, -8 and -9. Inhibition of either caspase-8 or caspase-9 abolished 
effector caspase-3 activation in µ1-expressing cells; however, the presence of broad-
spectrum caspase inhibitors augmented cytochrome c release indicating that activation 
of upstream caspases was not required for μ1-induced release of cytochrome c. Based 
on these findings, I hypothesize that µ1 plays a primary role in the activation of the 





The mammalian orthoreoviruses (reoviruses) are nonenveloped, icosahedral 
viruses that contain a segmented double-stranded RNA genome. Like many viruses, 
reoviruses induce apoptosis in infected cells both in vivo and in vitro [reviewed in (9)]. 
Reovirus-induced apoptosis is a primary determinant of neural and cardiac injury in 
mouse pathogenesis studies [reviewed in (9)]. A direct link between reovirus-induced 
apoptosis and tissue injury can be inferred from studies showing that pretreatment of 
mice with inhibitors of apoptosis lessen the pathologic changes in the CNS and heart 
(4, 16). Initial studies found that Type 3 reovirus strains induced apoptosis in tissue 
culture to a greater extent than Type 1 strains. The primary determinant of this strain 
difference was mapped to the S1 genome segment, which encodes the viral attachment 
protein, σ1, and a small nonstructural protein, σ1s. However, a consistent secondary 
determinant of strain differences in apoptotic efficiency mapped to the M2 gene 
segment, which encodes μ1, a major outer capsid protein (39). Investigations into the 
mechanism of reovirus-induced apoptosis have focused on the roles of σ1-receptor 
interactions and the ability of σ1s to induce cell cycle arrest (12, 23). However, Danthi 
et al. recently showed that specific receptor engagement by σ1 is not necessary to 
initiate reovirus-induced apoptosis. Furthermore these authors showed that under 
conditions where specific σ1 receptor engagements are circumvented, the µ1-encoding 
M2 genome segment is the primary determinant of reovirus-induced apoptosis (14). 
In addition to virus attachment, other early events during reovirus infection are 
important for apoptosis induction. Following engagement of the viral receptors (2), the 
virus enters the cell by clathrin-mediated endocytosis (18). Within endosomes and/or 
lysosomes the reovirus outer capsid proteins are proteolytically processed leading to 
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the degradation and removal of outer-capsid protein σ3 and an autocatalytic cleavage 
of µ1 occurs between residues 42 and 43 to form fragments termed µ1N and µ1C (5, 
32, 33). A cleavage at the C-terminus of the protein between residues 581-585 
generates N-terminal and C-terminal fragments called µ1δ/δ and φ, respectively (30) 
(see Chapter 1). The N-terminal autocatalytic cleavage of µ1 is necessary for 
membrane penetration and delivery of the viral core into the cytoplasm (33). Reovirus-
induced apoptosis is blocked by inhibiting endosomal acidification or inhibiting 
endosomal proteases, indicating that entry steps downstream of viral attachment are 
required for apoptosis induction. In addition, apoptosis can be induced even when 
viral RNA synthesis is inhibited, albeit with a high number of virus particles, 
indicating that membrane penetration and/or delivery of a fragment of the outer capsid 
proteins into the cytosol is involved in apoptosis induction (13). Recent studies have 
shown that expression of µ1, μ1C or the C-terminal φ fragment of μ1 in cells induces 
apoptosis, and that μ1, as well as the fragment φ, localizes to mitochondrial 
membranes (11). Danthi et al. have now shown that reovirus mutants with specific 
mutations in μ1 that decrease membrane penetration, while allowing similar levels of 
replication as wild type virus, are deficient in apoptosis induction in vitro and in their 
capacity to cause disease in mice (15). Taken together these findings suggest a 
prominent role for µ1 in reovirus-induced apoptosis. 
The apoptotic pathways that are activated during reovirus infection have been 
elucidated in some detail. Kominsky et al. showed that reoviruses activate both the 
extrinsic and intrinsic apoptotic pathways (26). In reovirus-induced apoptosis, the 
extrinsic pathway is initiated by binding of tumor necrosis factor (TNF)-related 
apoptosis inducing ligand (TRAIL) to the cell surface death receptors (DR) 4 and 5. 
Activation of these receptors leads to the formation of the death inducing signaling 
complex (DISC), resulting in activation of caspase-8. Activated caspase-8 can then 
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directly cleave and activate the effector caspase, caspase-3. In some cell types 
activated caspase-8 also cleaves the cytoplasmic Bcl-2 family protein Bid. The 
cleaved form of Bid, t-Bid, re-localizes to the outer mitochondrial membrane where it 
activates the proapoptotic Bcl-2 proteins Bax and Bak (10). Bax and Bak induce outer 
mitochondrial membrane permeabilization leading to release of cytochrome c and 
smac/DIABLO from the mitochondrial intermembrane space and activation of the 
intrinsic apoptotic pathway. Release of cytochrome c and smac/DIABLO occurs 
during reovirus-induced apoptosis (26, 27). Within the cytosol, released cytochrome c 
associates with heptameric Apaf-1 triggering a conformational change of Apaf-1 into a 
complex called the apoptosome (1). Caspase-9 then becomes activated in an ATP-
dependent manner upon recruitment of pro-caspase-9 to the apoptosome; Activated 
caspase-9 can then cleave caspase-3 (26). Inhibition of upstream/initiator caspase 
activation results in a decrease in caspase-3 activation in a number of cell types during 
reovirus infection (16, 26, 35). 
Although we now have insight into the cellular pathways reoviruses use to 
induce apoptosis, the mechanism by which the virus activates these pathways is 
largely unknown. The Parker laboratory has focused on the outer capsid protein µ1. 
Studies showed that μ1 induces apoptosis in transfected cells and that this activity is 
dependent on residues 582-675 at the C-terminus of the protein. In both transfected 
and infected cells μ1 localizes to mitochondria, the endoplasmic reticulum, and lipid 
droplets (11). In this study, I show that μ1 activates the mitochondrial (intrinsic) 
apoptotic pathway causing release of cytochrome c and smac/DIABLO from the 
mitochondrial intermembrane space. Broad-spectrum caspase inhibitors, which 
inhibited initiator caspases -8 and -9, failed to prevent μ1-induced release of 
cytochrome c from mitochondria. I found that both the intrinsic and extrinsic apoptotic 
pathways were activated in cells expressing µ1, and that inhibiting the initiator 
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caspases of either of these pathways led to a decrease in activation of caspase-3. These 
findings suggest that μ1 induces apoptosis in cells by a novel mechanism that requires 
initiator caspase activation to fully commit a cell to undergo apoptosis yet does not 
require activation of these caspases to cause release of mitochondrial intermembrane 
space proteins into the cytosol. 
 
Materials and Methods 
 
Cells. CHO-K1 cells were grown in Ham’s F-12 medium (CellGro); HeLa cells 
were grown in modified Eagle’s medium (MEM) with Earle’s Salt, both were 
supplemented with 10% fetal bovine serum (HyClone), 100 U/ml penicillin, 100 
μg/ml streptomycin, 1 mM sodium pyruvate and nonessential amino acids (CellGro). 
CHO-S suspension cells were grown in CHO-S-SFM II media (Gibco) supplemented 
with 100 U/ml penicillin and 100 μg/ml streptomycin.  
Antibodies and reagents. Mouse monoclonal antibodies (mAbs) to reoviral 
proteins μ1 (10F6, 10H2, 4A3), σ3 (5C3), and λ2 (7F4) have been previously 
described (38, 41). Polyclonal rabbit anti-virion (T1L) serum was a kind gift from Dr. 
Barbara Sherry. Mouse mAbs to cytochrome c and smac/DIABLO were from 
Pharmingen and Rabbit polyclonal IgG fraction against cleaved caspase-3 was from 
Cell Signaling Technologies. Secondary antibodies for immunofluorescence (IF) 
microscopy or flow cytometry were goat anti-mouse immunoglobulin G (IgG) and 
goat anti-rabbit IgG conjugated to Alexa 488, Alexa 594 or Alexa 647 (Invitrogen); or 
goat anti-mouse IgG subtype 1, 2a, or 2b specific conjugated to FITC, APC or PE 
(Jackson Labs). Zenon antibody labeling kits (Invitrogen) were used to directly label 
mouse mAbs with Alexa 488 or Alexa 594. Image-iT™ LIVE Green Caspase-8 
Detection Kit, Vybrant® FAM Caspase-3 and -7 Assay Kit, Vybrant® FAM Caspase-
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8 Assay Kit, TO-PRO®-3 , MitoTracker Deep Red 633 and 4’,6’-diamidino-2-
phenylindole (DAPI) were obtained from Invitrogen. FAM FLICA™ Caspase-
9 Assay Kit was obtained from Axxora. Broad-spectrum caspase inhibitor Q-VD-OPh 
(Kamiya Biomedical Company) was reconstituted and used according to the 
manufacturer’s directions at a final concentration of 20 µM. Caspase-8 and caspase-9 
inhibitors, Z-IETD-FMK and Z-LEHD-FMK respectively (R&D Systems, Inc), were 
reconstituted according to the manufacturer’s directions and used at the indicated 
concentration. Camptothecin (CPT) (Sigma) in DMSO was used at a final 
concentration of 20 µM. Etoposide (Sigma) in DMSO was used at a final 
concentration of 100 µM. Cells were incubated for 24 h at 37ºC after treatment with 
either CPT or etoposide. Valinomycin (Sigma) in DMSO was used at a final 
concentration of 100 nM. Cells were incubated for 10 mins at 37ºC following 
treatment with valinomycin.  
Plasmids. The reovirus M2 gene derived from the Type 1 Lang (T1L) and 
Type 3 Dearing-Nibert strains were expressed using the mammalian expression vector 
pCI-neo (Promega). Unless otherwise stated, pCI-M2 derived from T1L was used for 
experiments. In-frame truncation mutants of T1L were as previously described (11). 
In-frame fusions of T1L M2(582-708) to enhanced green fluorescent protein were also 
previously described (11). In-frame fusion of T1L M2(1-708) with pEGFP-C1 
(Clontech) was performed by PCR amplifying pCI-M2 (T1L) and digesting the 
product and vector with appropriate restriction enzymes. Primers and restriction 
enzymes were previously described (11). 
Transfections. For IF microscopy, CHO-K1 cells were seeded at 105 cells per 
well and HeLa cells were seeded at 2.5 x 105 in 6-well plates which contained 18 mm 
glass cover slips. Cells were transfected using FuGENE 6 transfection reagent (Roche) 
or Lipofectamine (Invitrogen) according to the manufacturer’s instructions and viewed 
32 
at 24 or 48 h post-transfection (p.t.). For flow cytometry, CHO-S cells were 
resuspended at a concentration of 5-10 x 105 cells per mL and transfected with 
FuGENE 6 or Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
instructions and analyzed at 24 h p.t. 
  Immunofluorescence (IF) microscopy. Cells on cover slips were rinsed with 
phosphate-buffered saline (PBS), fixed in 2% paraformaldehyde in PBS at room 
temperature for 10 min then washed in PBS. Cells were permeabilized with 0.15% 
Triton X-100 in PBS for 15 min at room temperature, and then blocked for 30-60 min 
with either 2% bovine serum albumin (BSA) or 10% normal goat serum (NGS) in 
PBS at room temperature (17, 20). All antibody incubations were carried out for 30-60 
min at room temperature in 10% NGS/PBS (when using Zenon antibody labeling kits) 
or PBS with 1% BSA and 0.1% Triton X-100 (PBSA-T). Cell nuclei were labeled 
with 300 nM 4',6'-diamidino-2-phenylindole (DAPI); coverslips were mounted using 
Prolong (Molecular Probes). Images were obtained with an inverted microscope 
(Nikon TE2000) equipped with fluorescence optics through a 60x 1.4 NA oil objective 
with 1.5x optical zoom. Images were collected digitally with a Coolsnap HQ charge-
coupled-device camera (Roper) and Openlab software (Improvision) then prepared for 
publication using Photoshop and Illustrator software (Adobe). 
Flow cytometry. After incubation, cells were harvested, and resuspended in 
media (when using caspase staining kits) or PBS. Caspase staining kits were used 
according to the manufacturer’s protocol, then cells were permeabilized for antibody 
staining with 0.14% Triton X-100, 1.8% BSA, 10% NGS in PBS for 20-30 min at 
room temperature. For mitochondrial staining, MitoTracker was added at a final 
concentration of 200 µM and cells were incubated for 30 min at 37ºC then fixed 
according to the manufacturer’s protocol. Cells were permeabilized with 0.15% Triton 
X-100 and 2% BSA in PBS for 10 min at room temperature and immunostained. 
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Cytochrome c release was determined by first incubating the cells in 250 mM sucrose, 
20 mM HEPES (pH 7.2), 10 mM KCl, 1.5 mM MgCl2, 2 mM EDTA, 8 mM 
dithiothreitol (DTT) with 150 μg/mL digitonin for 10 min at 4ºC to permeabilize the 
plasma membrane only (22). Cells were then fixed with 1.85% formaldehyde in PBS, 
and all membranes were permeabilized with 0.14% Triton X-100, 1.8% BSA, 10% 
NGS in PBS as indicated above. Antibody incubations were carried out at room 
temperature for 1-3 hours or 4ºC overnight in PBS with 1% BSA and 0.1% Triton X-
100 (PBSA-T). After antibody incubations cells were washed in PBS then 
resuspended in 1% paraformaldehyde in PBS. Cells transfected with green fluorescent 
protein (GFP) constructs were aliquoted and incubated with 1 µM TO-PRO®-3  for 15 
mins on ice. Flow cytometry data was collected with a FACSCalibur™ (BD) and 
analyzed with CellQuest™ (BD) and FlowJo (Tree Star, Inc.) software. Data from 
over 10,000 cells were analyzed, cells expressing viral protein were gated. Images 
were prepared for publication using Photoshop and Illustrator software (Adobe). 
Statistical Analysis.  Statistical analysis was performed using the software 
JMP 7 (SAS). Dunnett’s multi-comparison test was used to compare experimental 
values to the negative control. The drug treated positive control was significantly 
different when compared to the negative control in all of the figures in which 
statistical analyses were performed (p<0.05). Student’s t-test was used to compare two 
averages in the same data set.  All values used for statistical tests were derived from at 




Expression of μ1 in cells causes cytosolic release of cytochrome c and 
smac/DIABLO from the mitochondrial intermembrane space. Previously, Coffey 
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et al. have shown that expression of μ1 derived from the Type 1 Lang (T1L) reovirus 
strain in cells induces apoptosis (11). To identify the apoptotic pathways being 
activated, I first investigated the effect of μ1 expression on activation of the intrinsic 
apoptotic pathway by assessing release of cytochrome c and smac/DIABLO from 
mitochondria. In normal cells cytochrome c and smac/DIABLO are sequestered within 
the mitochondrial intermembrane space. Release of cytochrome c into the cytosol 
leads to formation of the apoptosome, which subsequently activates caspase-9, while 
release of smac/DIABLO causes repression of the cellular inhibitor of apoptosis 
proteins (cIAPs) which inhibit apoptosome formation (17, 28). HeLa and CHO-K1 
cells were transfected with plasmids expressing full-length µ1, pCI-M2(1-708), or a 
C-terminally truncated form of µ1 [µ1δ; pCI-M2(1-582)] that was previously shown  
not to induce apoptosis (11). Release of cytochrome c and smac/DIABLO was 
assessed 48 h p.t. by fluorescence microscopy. I found that μ1 expression in CHO-K1 
cells caused cytosolic release of cytochrome c seen as a dispersed staining pattern in 
the cytosol (Fig. 2.1 A top panel) as compared to images obtained from μ1δ-
expressing cells, which had a punctate pattern typical of cytochrome c retained in the 
mitochondria (Fig. 2.1 A bottom panel). I observed similar staining patterns for 
smac/DIABLO in cells expressing μ1 or µ1δ (Fig 2.2 A). To quantify this result and to 
determine which region of μ1 was responsible, HeLa and CHO-K1 cells were 
transfected with the following constructs: pCI-M2: (1-708)/μ1, (1-582)/μ1δ, (43-
582)/δ, (43-708)/μ1C, μ1(1-675); pEGFP-C1(vector) and pEGFP-M2(582-708)/φ. At 
24 or 48 h p.t., the cytosolic release of cytochrome c or smac/DIABLO was assessed 
by fluorescence microscopy. Approximately 85% of cells that expressed full-length 
μ1, µ1C or µ1(1-675), and 70% of cells that expressed EGFP-φ showed release of 
cytochrome c into the cytosol in CHO-K1 cells (Fig. 2.1 B). Similarly in HeLa cells 
over 60% of cells expressing µ1 constructs containing the (582-708)/φ region showed 
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release of cytochrome c from mitochondria (Fig. 2.1 C). Expression of those same 
constructs caused release of smac/DIABLO from mitochondria into the cytosol (Figs. 
2.2 B and C). In contrast, less than 10% of the cells expressing GFP or cells 
expressing μ1 constructs that lacked the (582-708)/φ region showed cytosolic release 
of cytochrome c or smac/DIABLO in either CHO-K1 or HeLa cells. I conclude that 
cellular expression of full-length μ1 or portions of μ1 that contain the φ region cause 
release of cytochrome c and smac/DIABLO from the mitochondrial intermembrane 
space into the cytosol. 
To further confirm this data, I used flow cytometry to quantify release of 
cytochrome c into the cytoplasm. In this approach, selective permeabilization of the 
plasma membrane prior to fixation and immunostaining allows cytoplasmic 
cytochrome c to escape from the cell resulting in a decrease in the fluorescent signal 
for cytochrome c (see Materials and Methods and Chapter 4). Using this technique, I 
found, similar to my findings using immunofluorescence microscopy in CHO-K1 and 
HeLa cells, significantly higher percentages of μ1-expressing cells (71%) showed 
cytochrome c release than control-transfected cells (6%) (p<0.05). In contrast, only 
12% of cells expressing δ showed cytochrome c release, which was not significantly 
different from control-transfected cells (Fig. 2.3 A). I conclude from these findings 
that expression of full-length μ1, but not the δ fragment of μ1, induces cytochrome c 
release. 
μ1 expression causes activation of the intrinsic and extrinsic apoptotic 
pathways in CHO-S cells and activation of both pathways is necessary for 
effector caspase activation. Previous studies showed that µ1 induces caspase-3 
activation when expressed in cells (11). Caspase-3 is activated by upstream caspases, 
caspase-8 and -9, during reovirus-induced apoptosis (26). Caspase-8 is an initiator 
caspase that is usually activated following ligation of members of the TNF receptor  
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Figure 2.1. Release of cytochrome c from the mitochondrial intermembrane space is 
mediated by the φ region of μ1. (A) CHO-K1 cells were transfected with pCI-M2(1-
708) to express μ1 (top panel) or pCI-M2(1-582) to express μ1δ (bottom panel). Cells 
were fixed at 48 h p.t., then immunostained with mouse anti-cytochrome c mAb 
followed by goat anti-mouse IgG conjugated to Alexa 488 and mouse anti-μ1 mAb 
conjugated to Alexa 594. Nuclei were stained with DAPI. Representative images of 
the predominant staining pattern of cytochrome c in cells expressing μ1 or μ1δ are 
shown. Scale bars, 5 μm. (B) CHO-K1 cells were transfected with the indicated 
constructs and stained at 48 h p.t. with mouse anti-cytochrome c mAb followed by 
goat anti-mouse IgG conjugated to Alexa 488 and mouse anti-μ1 mAb conjugated to 
Alexa 594. Cells transfected with pEGFP constructs were stained with mouse anti-
cytochrome c mAb followed by goat anti-mouse conjugated to Alexa 594. (C) HeLa 
cells were transfected with the indicated constructs, fixed at 24 h p.t., then 
immunostained as above. Transfected cells were scored as positive if they showed a 
dispersed cytochrome c staining pattern. One hundred transfected cells were scored for 
each sample. The means of three determinations (100 cells each) with standard 





Figure 2.2. Release of smac/DIABLO from the mitochondrial intermembrane space is 
mediated by the φ region of μ1. (A) CHO-K1 cells were transfected with pCI-M2(1-
708) to express μ1 (top panel) or pCI-M2(1-582) to express μ1δ (bottom panel). Cells 
were fixed at 48 h p.t., then immunostained with mouse anti-smac mAb followed by 
goat anti-mouse IgG conjugated to Alexa 488 and mouse anti-μ1 mAb conjugated to 
Texas Red. Nuclei were stained with DAPI. Representative images of the predominant 
staining pattern of smac/DIABLO in cells expressing μ1 or μ1δ are shown. Scale bars, 
5 μm. (B) CHO-K1 cells were transfected with the indicated constructs and 
immunostained at 48 h p.t. using mouse anti-smac mAb followed by goat anti-mouse 
subtype IgG1 conjugated to FITC (pCI constructs) or goat anti-mouse IgG conjugated 
to Alexa 594 (pEGFP constructs). Constructs expressing pCI-M2 proteins were 
detected by staining with mouse anti-μ1 mAb conjugated to Alexa 594. (C) HeLa cells 
were transfected with indicated constructs, fixed at 24 h p.t., then immunostained as 
above. Transfected cells were scored as positive if they showed a dispersed 
smac/DIABLO staining pattern. 100 transfected cells were scored for each sample. 





family by proapoptotic cytokines (34). Caspase-9 is activated upon assembly of the 
apoptosome pursuant to cytochrome c release (37). Activation of both extrinsic 
and intrinsic apoptotic pathways are required for reovirus-induced apoptosis (26). To 
determine if the extrinsic and/or intrinsic apoptotic pathways were activated by µ1, I 
used flow cytometry to monitor activation of caspases-8 and -9 in cells transfected 
with pCI-M2(1-708) [μ1], pCI-M2(43-582) [δ] or pCI-Neo [vector control]; or cells 
treated with 20 μM CPT or 100 µM ETP as positive controls. At 24 h p.t. cells were 
harvested and either stained for activated caspase-9 or activated caspase-8 and for µ1. 
A significant number, ~32% for activated caspase-9 (Fig. 2.3 B) and ~30% for 
activated caspase-8 (Fig. 2.3 C), of cells expressing µ1 had activated initiator caspases 
(p<0.05).  In contrast, only ~5% of vector-transfected or δ-expressing cells had 
activated caspase-9 or activated caspase-8.  I conclude from these findings that 
expression of full-length µ1, but not the δ fragment, induces activation of both 
extrinsic and intrinsic apoptotic pathways. 
Kominsky et al. proposed that cleavage of Bid by activated caspase-8 was 
necessary for activation of the intrinsic apoptotic pathway in HEK 293 cells during 
reovirus infection (26). I therefore wished to determine the effect of specific inhibitors 
of initiator caspases-8 and -9 on μ1-induced activation of caspase-3. Cells were 
transfected with the same constructs as above or treated with CPT. At the time of 
transfection, cells were treated with DMSO solvent control, caspase-8 inhibitor (Z-
IETD-FMK) or caspase-9 inhibitor (Z-LEHD-FMK), incubated for 24 h, then fixed 
and stained for activated caspase-3 and µ1. There were only very low levels of 
caspase-3 activation in pCI-Neo-transfected and δ-expressing cells, regardless of the 
presence or absence of caspase inhibitors. As expected, I found that a significantly 
greater percentage (p<0.05) of DMSO-treated µ1-expressing cells were positive for 
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Figure 2.3. µ1 expression activates the intrinsic and extrinsic apoptotic pathways 
which is necessary for effector caspase activation. (A) CHO-S cells were transfected 
with vector control (pCI-Neo), pCI-M2(1-708) to express µ1, pCI-M2(43-582) to 
express δ, or treated with 20 µM CPT. Cells were harvested 24 h p.t. and plasma 
membranes permeabilized with digitonin (see Materials and Methods). Cells were then 
fixed and stained using anti-T1L virion rabbit serum and anti-cytochrome c mouse 
mAb followed by goat anti-rabbit IgG Alexa 647 conjugated and goat anti-mouse IgG 
Alexa 488 conjugated secondary Abs. (B and C) CHO-S cells were transfected as 
above or treated with 20 µM CPT or 100 mM etoposide (ETP). At 24 h p.t. cells were 
stained for activated caspases -9 (B) and -8 (C) using FLICA kits. Cells were then 
fixed and stained using anti-µ1 mouse mAb followed by goat anti-mouse IgG Alexa 
647 conjugated secondary Ab. (D) CHO-S cells were transfected as above or treated 
with 20 µM CPT. At the time of transfection, cells were treated with DMSO (solvent 
control), 100 μM Z-IETD-FMK (caspase-8 inhibitor), or 100 μM Z-LEHD-FMK 
(caspase-9 inhibitor).  At 24 h p.t. cells were fixed and stained using anti-cleaved 
caspase-3 rabbit polyclonal Ab and anti-µ1 mouse mAb followed by goat anti-rabbit 
IgG Alexa 647 conjugated and goat anti-mouse IgG Alexa 488 conjugated polyclonal 
Ab. 10,000 cells were analyzed by flow cytometry for vector and drug treated 
controls; over 10,000 cells expressing µ1 and δ were analyzed. The means and 
standard deviations of at least three separate experiments are shown. 
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cleaved caspase-3 than the pCI-Neo-transfected, DMSO-treated control cells. 
Pretreatment of μ1-expressing cells with the caspase-8 (Z-IETD-FMK) and caspase-9 
(Z-LEHD-FMK) inhibitors significantly suppressed the μ1-induced activation of 
caspase-3 when compared to DMSO treated µ1-expressing cells (p<0.05) (Fig. 2.3 D). 
Similar results were obtained using 25 µM of each inhibitor (data not shown). I 
conclude that activation of both initiator caspases-8 and-9 is required for µ1-induced 
activation of caspase-3.  
Activation of caspase-3 by µ1 is not strain dependent. The capacity of 
reoviruses to induce apoptosis is strain-dependent, with Type 3 strains inducing 
significantly more apoptosis than Type 1 strains. Using reassortant genetics, the strain 
differences mapped to both the S1 and M2 genome segments (39). However when the 
step of virus binding to the receptor is circumvented, an analysis of Type 1 × Type 3 
reassortant viruses maps the strain difference in capacity to induce apoptosis to only 
the M2 genome segment (14). To determine if the μ1 protein of different reovirus 
strains induce different levels of apoptosis when expressed, cells were transfected with 
a control (pCI-Neo) or pCI-M2(1-708) derived from Type 1 Lang strain reovirus [pCI-
M2(T1L)], or pCI-M2(1-708) derived from Type 3 Dearing-Nibert strain reovirus, 
[pCI-M2 (T3D)]. Compared to the control (pCI-Neo) transfected cells, significantly 
more cells expressing µ1 showed activated caspase-3, indicating apoptosis induction 
(p<0.05) (Fig. 2.4). Furthermore, there was no significant difference in the apoptosis 
inducing capacity of the µ1 proteins derived from T1L or T3D reoviruses. These 
findings suggest that the phenotypic difference in reovirus-induced apoptosis is not 
determined at the protein level by the intrinsic capacity of μ1 to induce apoptosis. 
 Broad-spectrum caspase inhibitors do not prevent μ1-induced cytochrome c 
release in CHO-S cells and cause an increase in µ1 steady-state levels. Previous 




Figure 2.4. µ1-induced  activation of caspase-3 is strain-independent. CHO-S cells 
were transfected with vector control (pCI-Neo), pCI-M2(1-708) derived from the Type 
1 Lang reovirus strain [pCI-M2(T1L)], pCI-M2(1-708) derived from the Type 3 
Dearing-Nibert reovirus strain [pCI-M2(T3D-N)]. At 24 h p.t. cells were stained for 
activated caspase-3 using FLICA kits then fixed and immunostained using anti-µ1 
mouse mAb followed by goat anti-mouse IgG Alexa 647 conjugated antibodies.  
10,000 cells were analyzed by flow cytometry for pCI-Neo transfected and CPT 
treated cells.  Over 10,000 µ1 positive cells were analyzed for pCI-M2 (T1L) and pCI-
M2 (T3D) samples.  Graph shows means and standard deviations of at least three 
separate experiments. 
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reovirus-induced apoptosis. In addition, it was suggested that activation of caspase-8 
during reovirus infection occurs upstream of activation of the mitochondrial (intrinsic) 
apoptotic pathway based on data showing that cells expressing a dominant-negative 
form of FADD, an adapter protein necessary for downstream signaling, failed to 
release cytochrome c in response to reovirus infection (26). In order to determine if 
caspase activation was necessary for µ1 induced cytochrome c release, cells were 
transfected with pCI-M2(1-708) [μ1], pCI-M2(43-582) [δ] or pCI-Neo [vector 
control]; or treated with 20 μM CPT. Transfected cells were treated with either 20 µM 
of the broad-spectrum caspase inhibitor Q-VD-OPh or a DMSO solvent control at the 
time of transfection. In preliminary experiments, I found that a concentration of 20 
µM Q- VD-OPh inhibited activation of caspases-3, and -8 (Fig. 2.5 A) as well as 
caspase-9 (data not shown) in cells transfected with pCI-M2(1-708) [μ1] at 24 h p.t. 
Also, the addition of 20 µM Q-VD-OPh to CPT-treated cells decreased the numbers of 
cells with caspase-3 activation by ~40% (data not shown). At 24 h p.t. cells were 
harvested, and immunostained for cytochrome c and µ1 then analyzed by flow 
cytometry. As before, there was no substantial release of cytochrome c in cells 
transfected with pCI-neo or pCI-M2(43-582) [δ] irrespective of treatment with DMSO 
or Q-VD-OPh (Fig. 2.5 B).  However, I found that rather than inhibiting cytochrome c 
release, Q-VD-OPh treatment of cells transfected with pCI-M2(1-708) [μ1] enhanced 
the release of cytochrome c (p<0.07). 79% of Q-VD-OPh-treated μ1-transfected cells 
released cytochrome c compared to 66% DMSO-treated μ1-transfected cells, both of 
which were significantly different from pCI-Neo transfected, DMSO treated cells 
(p<0.05) (Fig. 2.5 B). I conclude from these findings that activation of upstream 
caspases is not necessary for release of cytochrome c in µ1-expressing cells, and that a 
greater number of cells release cytochrome c when activation of caspases is blocked 
(see Discussion). 
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 An additional phenomenon observed in this experiment was a dramatic shift in 
the distribution of the population of µ1-positive cells. As illustrated in Figure 2.5 C 
top left panel, µ1-expressing cells treated with DMSO were weakly positive for μ1, 
whereas δ-expressing cells treated with DMSO stained strongly positive with this 
population of cells spanning decades two through four (Fig. 2.5 C, top right).  When 
Q-VD-OPh was added to cells expressing δ there was little change in the geometric 
mean of fluorescence (Fig. 2.5 C, bottom right); however, in cells expressing μ1 there 
was a dramatic increase in the geometric mean of fluorescence of μ1-positive cells, as 
illustrated by the shift in the population to the right (Fig. 2.5 C, bottom left).  
Furthermore, a comparison of the top left and bottom left panels of Fig. 2.5 C shows 
that a population of µ1-negative and cytochrome c-negative cells (Fig. 2.5 C, top left), 
appears to become µ1-positive and cytochrome c negative upon addition of Q-VD-
OPh (Fig. 2.5 C, bottom left). The geometric mean of fluorescence of the µ1- or δ-
expressing cells for three independent experiments was quantified and revealed that 
incubation with Q-VD-OPh increased the average geometric mean of fluorescence in 
µ1-expressing cells two-fold over µ1-expressing cells treated with DMSO. In contrast, 
δ-expressing cells show a slight decrease in the average geometric mean of 
fluorescence when incubated with Q-VD-OPh as opposed to DMSO (Fig. 2.5 D).  
From this data, I conclude that broad-spectrum caspase inhibitors cause an increase in 
the steady-state protein levels of μ1 in cells.  I also conclude that treatment of μ1-
expressing cells with Q-VD-OPh unmasks a population of cells that express very low 
levels of immunoreactive µ1 and are negative for cytochrome c such that μ1 in these 
cells becomes detectable with antibodies.  I hypothesize that this is due to internal 
caspase cleavage sites in the µ1 protein (see below and Discussion). 
 µ1 induces cytochrome c release from the cell as well as from the 
mitochondria. I suspected that the low steady-state levels of µ1 present in transfected 
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Figure 2.5. Broad-spectrum caspase inhibitor Q-VD-OPH prevents μ1-induced 
caspase-3 and caspase-8 activation and augments µ1-induced cytochrome c release 
from mitochondria. (A) Untransfected or transfected  [pCI-M2(1-708) (µ1)] CHO-S 
cells were  treated with DMSO or 20 μM Q-VD-OPh and stained for caspase-8 
activation using FLICA kits, or for caspase-3 cleavage, using anti-cleaved caspase-3 
rabbit polyclonal Ab followed by goat anti-rabbit IgG Alexa 647 conjugated Ab. 
10,000 cells were analyzed by flow cytometry. Representative histograms are shown. 
(B) CHO-S cells were transfected with pCI-Neo (vector control), pCI-M2(1-708) (µ1), 
pCI-M2(43-582) (δ), or treated with 20 µM CPT. At the time of transfection 20 µM 
Q-VD-OPh or v/v DMSO was added to the cultures. Cells were harvested at 24 h p.t., 
plasma membranes permeabilized (see Materials and Methods), then fixed and stained 
using anti-T1L virion rabbit serum and anti-cytochrome c mouse mAb followed by 
goat anti-rabbit IgG Alexa 647 conjugated and goat anti-mouse IgG Alexa 488 
conjugated secondary Abs. Cells were analyzed by flow cytometry. 10,000 cells were 
analyzed for vector and drug treated controls; over 10,000 cells expressing µ1 and δ 
were analyzed. The means and standard deviations of at least three separate 
experiments are shown.  (C) Representative contour plots of samples analyzed in (B).  
(D) The geometric mean of the fluorescent channel of µ1 or δ positive cells treated 
with DMSO was subtracted from the geometric mean of the fluorescent channel of µ1 
or δ positive cells treated with Q-VD-OPh. Graph shows means of this value and 




cells in the absence of caspase inhibitors was in part a consequence of critical 
antigenic epitopes of the protein being destroyed secondary to caspase cleavage (see 
Fig. 2.5). Therefore, I used a GFP-tagged µ1 construct to further investigate the 
release of cytochrome c in the presence and absence of broad-spectrum caspase 
inhibitors. Furthermore, I compared total levels of cytochrome c in cells with levels of 
cytochrome c in the mitochondria by incubating cells in buffer without digitonin (total 
cytochrome c) or with digitonin (mitochondrial cytochrome c) prior to fixation (see 
Materials and Methods and Chapter 4).  
 CHO-S cells were transfected with vector control (pEGFP-C1) full length µ1 
[pCI-M2(1-708)] or GFP-tagged µ1 [pEGFP-C-M2(1-708)] and 20 µM Q-VD-OPh or 
an equal volume DMSO was added at the time of transfection.  Cells were stained for 
cytochrome c (constructs with GFP) and µ1 (pCI-M2 constructs). Treatment with 
DMSO and Q-VD-OPh had little effect on GFP-expressing cells; however, 
permeabilizing the plasma membrane with digitonin resulted in a decrease in GFP 
associated fluorescence, suggesting that GFP was washed out of the cells before 
fixation (Fig.2.6: compare panels 1 & 2 and 3 & 4). In contrast, μ1 and GFP-µ1 were 
retained in cells with a permeabilized plasma membrane (Fig. 2.6: panels 6, 8, 10, and 
12). µ1 has been shown to interact with cellular membranes in infected and transfected 
cells (11), and it seems likely that this explains the retention of µ1 within cells whose 
plasma membrane has been permeabilized with digitonin.  As expected, cells 
transfected with pEGFP-C1 retained cytochrome c in their mitochondria as indicated 
by the lack of effect digitonin had on immunostaining for cytochrome c (Fig. 2.6 
compare panels 1 & 2 and 3 & 4).  
 In DMSO-treated μ1-expressing cells, I noted a population of cells that were 
cytochrome c negative even though the cells had not been permeabilized with 
digitonin — i.e. cytochrome c had been released completely from the cell (Fig. 2.6: 
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panel 5); in addition, this population of cells was µ1-negative. Permeabilizing the 
plasma membrane with digitonin changed the distribution of these cytochrome c 
negative cells such that they were weakly µ1-positive (Fig. 2.6 compare panels 5 & 6). 
The addition of the broad-spectrum caspase inhibitors shifted the cytochrome c-
negative population to become cytochrome c-positive and µ1-positive (Fig. 2.6 
compare panels 5 & 7). By permeablizing the plasma membrane of the Q-VD-OPh 
treated cells, the population shifted from cytochrome c-positive and µ1-positive to 
cytochrome c negative and µ1-positive (Fig. 2.6 compare panels 7 & 8).  Another 
comparison can be made between panels 6 & 8 of Figure 2.6 in that the [weakly] µ1-
positive and cytochrome c negative population in panel 6 becomes definitively µ1-
positive and cytochrome c negative in panel 8, again indicating that a substantial 
portion of μ1-expressing cells release cytochrome c into the cytoplasm and that broad-
spectrum caspase inhibitors increased the levels of immunodetectable µ1.  
 Unlike cells transfected with pCI-M2(1-708)μ1 (see above), cells transfected 
with pEGFP-C-M2 did not contain a subpopulation of cells that were cytochrome c 
negative and GFP-µ1-negative, but rather contained a population of cells that were 
cytochrome c negative and GFP-µ1-positive (Fig. 2.6 compare panels 5 & 9).  
Permeabilizing the plasma membrane of cells transfected with pEGFP-C-M2 with 
digitonin decreased the cytochrome c fluorescence signal even further in those cells 
positive for GFP-μ1 (Fig. 2.6 compare panels 9 & 10).  Similar to µ1-expressing cells 
that were treated with Q-VD-OPh, when GFP-µ1-expressing cells were treated with 
Q-VD-OPh the GFP-μ1 positive population stained mostly positive for cytochrome c 
(Fig. 2.6 compare panels 7 & 11), indicating these are similar cell populations.  Upon 
plasma membrane permeabilization the GFP-µ1-expressing and cytochrome c positive 
population became cytochrome c negative (Fig. 2.6 compare panels 11 & 12). This  
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Figure 2.6. µ1 induces release of cytochrome c from the cell. CHO-S cells were 
transfected with pEGFP-C1, pCI-M2(1-708) to express µ1, or pEGFP-C-M2(1-708) to 
express GFP-µ1. At the time of transfection cells were treated with either 20 µM Q-
VD-OPh or the same volume DMSO as indicated above the dot plots. Cells were 
incubated for 24 h, spun down and resuspend in buffer with or without digitonin 
(indicated by -/+ ), fixed, permeabilized, and stained using anti- cytochrome c mouse 
mAb followed by goat anti-mouse IgG Alexa 647 conjugated Ab (GFP constructs) and 
anti-T1L rabbit serum followed by goat anti-rabbit IgG Alexa 488 conjugated Ab 
(pCI-M2 constructs).  GFP fluorescence and anti-T1L/goat anti-mouse Ab 
fluorescence are shown in FL-1 channel along the x-axis (log scale).  Anti-cytochrome 




population shift is identical to the response observed in similarly treated µ1-expressing 
cells (Fig. 2.6 compare panels 7 & 8 to 11 &12).  
 Taken together, these data confirmed the data in Figure 2.5 inferring that µ1 
induces cytochrome c release from mitochondria even in the presence of broad-
spectrum caspase inhibitors, and that broad-spectrum caspase inhibitors affect the 
steady-state levels of µ1 as detected by immunofluorescence.  Furthermore, my data 
showed that the majority of GFP-µ1-expressing cells lost cytochrome c from the cell 
prior to permeabilization of the plasma membrane suggesting that µ1 may play a 
direct role in permeabilization of the plasma membrane. I also inferred that 
permeabilization of the plasma membrane as a result of µ1 expression occurs in the 
pCI-M2(1-708) transfected cells. This is illustrated by the shift in the cytochrome c 
negative population (Fig. 2.6: panel 5) to weakly µ1-positive and cytochrome c-
negative (Fig. 2.6: panel 6) to µ1-positive and cytochrome c-positive (Fig. 2.6: 7). One 
possible explanation for the µ1-negative and cytochrome c-negative population in 
cells transfected with pCI-M2(1-708) is that the epitopes on μ1 that are recognized by 
the anti-virion serum are destroyed, perhaps as a consequence of caspase-cleavage. 
However, by using the GFP-µ1 construct, the data shows a population of GFP-µ1 cells 
that have released cytochrome c not only from the mitochondria, but from the cell. 
Interestingly, the GFP-µ1-positive and cytochrome c negative population shifted 
upward when cells were treated with Q-VD-OPh (Fig. 2.6 compare 9 & 11), 
suggesting that activated caspases might be required for μ1-induced plasma membrane 
permeabilization to occur.  
 µ1 expression in CHO-S cells results in plasma membrane permeabilization, 
yet mitochondrial membrane potential remains intact. Previous studies have 
shown that during reovirus-induced apoptosis cells exhibit classical signs of apoptosis 
such as plasma membrane blebbing, nuclear condensation, and cell shrinkage (39). 
53 
Although necrosis and apoptosis are often referred to as separate mechanisms for cell 
death, they are not mutually exclusive events [reviewed in (19)]. Given the propensity 
of µ1 to associate with membranes (11) and its capacity to induce caspase-independent 
release of cytochrome c, I hypothesized that µ1 expression might compromise the 
plasma membrane. In order to determine if cells expressing µ1 maintain plasma 
membrane integrity, CHO-S cells were transfected with pEGFP-C-M2(1-708) [GFP-
μ1], pEGFP-C-M2(582-708) [GFP-φ] or pEGFP-C1 [vector control] and treated with 
DMSO or Q-VD-OPh at the time of transfection. After 24 h cells were stained with 
the cell membrane-impermeant fluorescent dye TO-PRO®-3 and analyzed by flow 
cytometry. Approximately 17% of GFP-µ1-expressing cells and GFP-φ-expressing 
cells were stained positively for TO-PRO®-3, indicating loss of plasma membrane 
integrity. However, less than 8% of GFP expressing cells were TO-PRO®-3 positive. 
The broad- spectrum caspase inhibitor, Q-VD-OPh, decreased the percentage of TO-
PRO®-3  positive GFP-µ1 and GFP- φ- transfected cells slightly (to ~11% of GFP-µ1 
or GFP-φ expressing cells) and to less than 4% for GFP-expressing cells (Fig. 2.7A). 
Cells positive for GFP-µ1 (or GFP-φ) and TO-PRO®-3 formed a distinct population 
from single-positive GFP-µ1 or GFP-φ cells. However, all of these cells had similar 
forward and side scatter parameters (Fig. 2.7 B). Treatment with Q-VD-OPh caused a 
decrease in forward and side scatter of the single-positive cells; the double-positive 
population remained consistent regardless of treatment with DMSO or Q-VD-OPh. 
The forward and side scatter data from the permeabilized cells indicate they have 
similar refractive index as the intact cells. From these data, I conclude that expression 
of µ1 or φ leads to increased permeability of the plasma membrane allowing access of 
TO-PRO®-3 without substantial changes in cell morphology.  
 Reovirus-induced apoptosis has been reported to occur without loss of 
mitochondrial membrane potential (27). This is in contrast to other viruses such as 
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Human T-lymphocyte virus-1 and Walleye dermal sarcoma virus that induce 
dissipation of the mitochondrial membrane potential (6). Therefore, the mitochondrial 
membrane potential of cells expressing µ1 was examined. In this experiment, cells 
were transfected with pCI-M2(1-708) [μ1], pCI-M2(43-582) [δ] or pCI-Neo [vector 
control] or treated with 100 nM valinomycin as a positive control. Transfected cells 
were either treated with 20 µM Q-VD-OPh or with DMSO. Valinomycin-treated cells 
show a left-shifted peak, indicating decreased uptake of MitoTracker by each cell, 
whereas I observed a slight right shift in the peaks of DMSO-treated cells expressing 
either µ1 or δ compared to the vector-control, indicating an increase in MitoTracker 
fluorescence. (Fig. 2.7 C). µ1 and δ-expressing cells treated with Q-VD-OPh had 
similar levels of MitoTracker uptake as vector-control transfected cells. I conclude 
that despite the release of proapoptotic proteins from the mitochondria, the 




 In this study, I have shown that expression of reovirus outer capsid protein µ1 
activated the initiator caspases, caspase-8 and -9, and induced cytochrome c and 
smac/DIABLO release from the mitochondrial intermembrane space. These events 
also occur during reovirus-induced apoptosis (10, 26, 27) and thus my study provides 
further evidence that μ1 is a major factor responsible for reovirus-induced apoptosis. 
Reovirus-induced apoptosis is blocked by preventing activation of caspase-8 (10); 
similarly, I found that blocking activation of either caspase-8 or caspase-9 prevented 
activation of effector caspase-3 in cells expressing µ1. Reovirus-induced apoptosis is 
also blocked by overexpression of the anti-apoptotic protein Bcl-2. This was presumed 
to be due to preventing the activation of proapoptotic Bcl-2 family members, Bax and 
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Figure 2.7. Expression of GFP-µ1 or GFP-φ leads to plasma membrane 
permeabilization; however mitochondrial membrane potential is maintained in cells 
expressing µ1. (A) CHO-S cells were transfected with vector control (pEGFP-C1), 
pEGFP-C-M2(1-708) to express GFP-µ1, or pEGFP-C-M2(582-708) to express GFP-
φ. Simultaneously, cells were treated with 20 µM Q-VD-OPh or the same volume of 
DMSO as a control. At 24 h p.t. cells were placed on ice and incubated with 1 µM 
TO-PRO®-3  for 15 mins. As a positive control, untransfected cells were treated with 
0.1% Triton for 15 mins before the addition of TO-PRO®-3 . Cells were analyzed by 
flow cytometry. 10,000 cells were analyzed for the controls, and over 10,000 cells 
expressing GFP, GFP-µ1, or GFP-φ were analyzed. Dot plots of one representative 
experiment are shown. Dot plots show GFP fluorescence on the x-axis (log scale) and 
TOPRO-3 fluorescence on the y-axis (log scale). Percentages shown are of the total 
population analyzed. (B) Dot plots show forward scatter on the x-axis and side scatter 
on the y-axis (linear scale) of the samples shown in A. Single-positive (GFP-µ1-
expressing cells) were gated, and are shaded grey. Double-positive (GFP-µ1-
expressing cells that are TOPRO-3 positive) were gated, and are shaded black. The dot 
plot on the left shows cells that were treated with DMSO, the dot plot on the right 
shows cells that were treated with Q-VD-OPh. (C) CHO-S cells were transfected with 
vector control (pCI-Neo, dashed line), pCI-M2(1-708) to express µ1(solid line), or 
pCI-M2(43-582) to express δ (dotted line). Simultaneously, 20 µM Q-VD-OPh or the 
same volume DMSO was added to the cultures. Control cells were treated with 100 
nM valinomycin for 10 mins prior to MitoTracker staining (‘+’-shaded grey). At 24 h 
p.t. MitoTracker Deep Red was added to the cell cultures at a final concentration of 
200 nM and incubated for 20 mins at 37ºC on a shaker. Cells were than washed, fixed, 
permeabilized and immunostained. µ1 and δ were detected using anti-µ1 mouse mAbs 
and goat anti-mouse IgG conjugated to Alexa 488. Data was collected by flow 
cytometry. 10,000 pCI-Neo transfected and valinomycin-treated cells were analyzed 
and over 10,000 cells expressing µ1 or δ were analyzed. Representative histogram 
overlays of these populations measuring MitoTracker fluorescence are shown.
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Bak, and thus preventing their permeabilization of the outer mitochondrial membrane 
(25, 36). However, in µ1-expressing cells, I found that cytochrome c was released in 
the presence of broad-spectrum caspase inhibitors, indicating that caspase activation is 
not required for outer mitochondrial membrane permeabilization induced by µ1. One 
possible explanation for this observation is that μ1 can permeabilize mitochondrial 
membranes independently of Bax and Bak. As μ1 is known to be important in 
membrane permeabilization during virus entry, it seems feasible that similar 
permeabilization of intracellular membranes could occur when µ1 interacts with them. 
I am currently examining these possibilities (see Chapter 3). 
Caspase-8 activation most commonly occurs in response to binding of 
cytokines, such as TNF, TRAIL, or Fas, to TNF family death receptors (34). In 
reovirus-induced apoptosis, TRAIL binding to death receptors 4 and 5 induces 
formation of the death-inducing signaling complex and activation of caspase-8; 
blocking this activation protects cells from apoptosis (10). However, the mechanism 
by which reovirus infection leads to TRAIL secretion has not been identified. Here I 
found that, similar to the situation in reovirus-infected cells, inhibiting caspase-8 
activation through the use of Z-IETD-FMK prevented downstream apoptosis induction 
in cells expressing µ1. However, I also found that μ1-expressing cells that were 
treated with the pan-caspase inhibitor Q-VD-OPh released cytochrome c from 
mitochondria suggesting that both the intrinsic and extrinsic apoptotic pathways are 
activated independently in these cells. These results indicate that activation of both 
caspases-8 and -9 was required for μ1-induced downstream activation of caspase-3. 
Mechanisms that might be responsible for caspase-8 activation in cells expressing µ1 
include μ1-induced secretion of TRAIL, the cytosolic release of lysosomal cathepsins 
(3) and ER-stress mediated mechanisms (24). Inhibiting cathepsins L or D blocks 
caspase-8 activation in cells undergoing apoptosis induced by oxidative stress (3). 
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Alternatively, it has been proposed that ER stress causes an accumulation of proteins 
with death domains (DD) at the ER membrane, thus inducing caspase-8 activation 
(24).  
It is unclear why activation of both extrinsic and intrinsic apoptotic pathways 
is independently required for μ1-induced apoptosis. One possibility is that a threshold 
level of proapoptotic signals must be reached in order to tip the balance towards 
apoptosis. Activation of either the extrinsic or intrinsic pathway might not meet this 
threshold and only activation of both pathways leads to commitment to apoptosis. 
During infection, activation of caspase-8 together with cleavage of Bid causes an 
amplifying effect on mitochondrial outer membrane permeabilization that would be 
mediated by Bax and Bak. I am currently examining the ramifications of Bax and Bak 
deficiency to µ1 induced apoptosis (see Chapter 3).  
 Mitochondria are the energy-generating engines of the cell. In order to 
efficiently generate ATP by oxidative phosphorylation, an electrochemical H+ gradient 
across the inner mitochondrial membrane [the inner mitochondrial transmembrane 
potential (ΔΨm)] is maintained [reviewed in (7)]. Changes in ΔΨm can occur 
secondary to opening of the permeability transition pore complex (PTPC). This 
complex putatively contains several proteins, including the voltage-dependent anion 
channel and the adenine nucleotide transporter 1, that are regulated under physiologic 
conditions to allow transient opening of the pore and movement of metabolites from 
the inner mitochondrial matrix [reviewed in (40)]. Many physiological conditions, 
pharmacological agents, and viral proteins interact with the proteins that mediate or 
form the PTPC to either induce or prevent apoptosis (6, 21). Generally, apoptosis is 
associated with the dissipation of ΔΨm; however this is not the case in all scenarios. 
One explanation involves the temporary opening of the PTPC, in which the loss of 
ΔΨm is not sustained. Also, other evidence suggests that ATP is necessary for the cell 
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to undergo apoptosis, whereas loss of ATP results in the cell undergoing necrosis 
[reviewed in (21)]. It has been shown that reovirus-induced apoptosis proceeds 
without loss of ΔΨm (27). Apoptosis induced by a proapoptotic BH3-only protein, 
Bims, does not alter the mitochondrial membrane potential even though both reovirus 
and Bims-induced apoptosis involve the intrinsic apoptotic pathway (26, 27, 42). 
Similarly, I found that µ1-induced apoptosis did not lead to loss of the ΔΨm, although 
I cannot rule out the possibility that the membrane potential is transiently lost during 
µ1-induced apoptosis.    
An additional observation I made during this study was the increased steady-
state levels of µ1 in transfected cells treated with caspase inhibitors. The levels of µ1 
detected by flow cytometry increased approximately two-fold in transfected cells that 
were treated with Q-VD-OPh when compared to transfected cells treated with DMSO. 
In contrast, the steady-state levels of δ seemed to decrease in response to caspase 
inhibitors. Additionally, when Q-VD-OPh was added, a greater percentage of 
cytochrome c negative cells were µ1 positive, and an entire population of cells shifted 
from µ1 negative/cytochrome c negative (without digitonin) to µ1 positive/ 
cytochrome c positive (with Q-VD-OPh, without digitonin). Previous speculation was 
that the increase in steady-state levels of µ1 in response to caspase inhibitors results 
from blocking translational shut-off that occurs secondary to apoptosis (11). However, 
an additional or alternative explanation is that µ1 itself is targeted by caspases for 
cleavage such that µ1 levels are autoregulated. Our preliminary studies indicate that 
mutation of predicted caspase cleavage sites in μ1 leads to increased steady state 
levels of this protein (Wisniewski, Hom, and Parker, unpublished data). 
In light of the data presented here, I believe that µ1 has a direct or indirect 
effect on cellular membranes. µ1 has previously been shown to associate with 
intracellular membranes, and that this association correlates with apoptosis induction 
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(11). Additionally, µ1 plays a role in the escape of reoviruses from the endo-lysosome 
via membrane penetration (8, 30, 31). Therefore, I hypothesize that µ1, alone or in 
concert with other cellular proteins, can permeabilize the plasma membrane, outer 
mitochondrial membrane, and possibly the ER. Permeabilization of the outer 
mitochondrial membrane results in cytochrome c and smac/DIABLO release with 
subsequent caspase-9 activation. Caspase-9 and caspase-8 are both activated in cells 
expressing µ1, thus initiating the caspase cascade, which ultimately leads to apoptosis 
of the cell (17, 28, 43). Currently, I am unsure of the mechanism of caspase-8 
activation in cells expressing µ1; however, it is possible that this could occur through 
interactions with membranes as well (3, 24). During reovirus infection, the interaction 
of µ1 with cellular membranes is kept to a minimum by assembly of μ1 with its 
partner reovirus outer capsid protein, σ3 [(29) and unpublished data]. I believe that µ1 
is the key determinant for inducing apoptosis during reovirus infection, and that this 
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REOVIRUS STRAIN T3D AND EXPRESSION OF STRUCTURAL PROTEIN µ1 
INDUCES CYTOCHROME C RELEASE FROM THE MITOCHONDRIA IN BAX-/-




Reovirus strain Type 3 Dearing (T3DN) has been shown to induce apoptosis by 
activating the extrinsic and intrinsic apoptotic pathways. Previous studies have shown 
that HEK 293 cells expressing a dominant negative FADD, an adaptor molecule 
necessary for activation of caspase-8, does not release cytochrome c or activate the 
intrinsic apoptotic pathway in response to reovirus infection. Reovirus outer-capsid 
protein µ1 induced apoptosis when expressed in cells by activating both the intrinsic 
and extrinsic apoptotic pathways. Expression of µ1 in the presence of a broad-
spectrum caspase inhibitor prevented initiator and effector caspase activation; 
however, it increased the percentage of µ1-expressing cells that released cytochrome c 
from the mitochondria. In this study, the ability of reovirus strain T3DN and µ1-
expression to induce cytochrome c release in a Bcl-2 independent manner is addressed 
using wild-type, Bak-/-, Bax-/-, and Bax-/-Bak-/- immortalized mouse embryonic 
fibroblasts (MEFs). I found that Bax-/-Bak-/-MEFs release cytochrome c from the 
mitochondria in response to reovirus infection and µ1 expression. However, 
cytochrome c release in response to infection is augmented in wild-type and Bax-/- 





Activation of the intrinsic and extrinsic apoptotic pathways occurs during 
reovirus-induced apoptosis. Kominsky et al. proposed that activation of the extrinsic 
apoptotic pathway is initiated by TNF-related apoptosis inducing ligand (TRAIL) 
binding to death receptors and activating caspase-8 (6). Activated caspase-8 can 
cleave a pro-apoptotic Bcl-2 family protein Bid to tBid. tBid relocalizes to the outer 
mitochondria membrane activating pro-apoptotic proteins Bax and Bak resulting in the 
activation of the intrinsic apoptotic pathway (9). Studies showed that a dominant 
negative FADD mutation, which prevents downstream signaling of activated caspase-
8, blocked activation of the intrinsic apoptotic pathway and caspase-3 cleavage during 
reovirus infection (6). In a further study, Kominsky et al. showed that overexpression 
of the anti-apoptotic protein Bcl-2 prevented release of cytochrome c and 
smac/DIABLO from the mitochondrial intermembrane space (7). It is not known 
exactly how overexpression of Bcl-2 blocks apoptosis during reovirus infection. Most 
likely, Bcl-2 acts to sequester activator proteins such as tBid and Bim which can 
directly interact with and activate Bax and Bak (5). 
Dysfunction of the expression of Bax or Bak has been associated with multiple 
pathological conditions including, but not limited to, cancer including non-Hodgkin’s 
lymphomas, autoimmune disorders such as lupus, ischemia-reperfusion injury, and 
Alzheimer’s disease. Bax and Bak, as well as other Bcl-2 proteins, have α-helical and 
channel-like tertiary structures resembling that of pore-forming bacterial toxins (10).  
A single cell analysis of the distribution of Bax and Bak in apoptotic cells showed 
that, upon activation, Bax translocates from the cytoplasm to the outer mitochondrial 
membrane, forms small complexes at the outer mitochondrial membrane, then forms 
large complexes at the outer mitochondrial membrane. The step at which Bax forms 
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small complexes correlates with cytochrome c release from the mitochondrial 
intermembrane space. Bak undergoes similar changes, with the exception that this 
protein does not need to undergo translocation to the outer mitochondrial membrane, 
as it is already loosely associated there (16). Insertion of parts of the α-helical 
structures anchor the Bcl-2 proteins as monomers or dimers to the mitochondrial 
membrane. The hypothesis is that Bax and Bak undergo oligomerization, possibly 
another conformational change, allowing pore formation in the outer mitochondrial 
membrane. Both Bax and Bak are capable of permeabilizing membranes including 
liposomes in cell free systems, and are suggested to have somewhat redundant roles in 
permeabilizing the outer mitochondrial membrane to induce apopotosis [reviewed in 
(8)].  
Wei et al. generated Bak-/- mice, Bax-/- mice and Bax-/-Bak-/- double knockout 
(DKO) mice, though only a small percentage of DKO mice were viable. Additionally, 
they isolated and immortalized (with SV40) mouse embryonic fibroblasts (MEFs) 
from the single and DKO mice as well as wild-type mice. The single knockout and 
wild-type cells were susceptible to multiple apoptosis-inducing stimuli that act 
through the extrinsic, intrinsic, and ER-stress pathways including staurosporine, 
etoposide, ultraviolet radiation, thapsigargin and tumor necrosis factor 
(TNF)/actinomycin D. However, DKO cells were resistant to all apoptosis inducers 
except those that activate the extrinsic apoptotic pathway such as TNF/actinomycin D. 
Furthermore, while the single knockout and wild-type cells released cytochrome c in 
response to appropriate apoptosis inducers, DKO MEFs failed to release cytochrome c 
from the mitochondrial intermembrane space (14). Additional studies with DKO 
MEFs placed initiator and effector caspase activation downstream of Bax and Bak 
activation for multiple stimuli, including DNA damage and ER stress. Thus, no 
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caspase that contained a caspase-associated recruitment domain (CARD) was 
activated in DKO MEFs (11). 
In Chapter 2, I showed that both the extrinsic and intrinsic apoptotic pathways 
must be activated in order to activate caspase-3 during µ1-induced apoptosis. 
However, µ1-expression induced the release of cytochrome c from the mitochondrial 
intermembrane space in the presence of broad-spectrum caspase inhibitors. This 
implies that permeabilization of the outer mitochondrial membrane in response to μ1 
expression proceeds without Bid cleavage or Bax and Bak activation. In order to test 
this hypothesis, I investigated the ability of reovirus or the expression of µ1 to induce 
cytochrome c release in Bax-/-, Bak-/-, and DKO MEFs obtained from the late Dr. 
Stanley Korsmeyer. 
 
Materials and Methods 
 
 Cells and virus. Wild-type, Bax-/-, Bak-/- and Bax-/-Bak-/- (DKO) mouse 
embryonic fibroblasts that had been transformed with SV40 T antigen (14) were 
grown in Dulbecco’s Modified Eagle’s Medium (DMEM High Glucose) (Cellgro) 
supplemented with 10% fetal bovine serum (HyClone), 100 U/ml penicillin, 100 
μg/ml streptomycin, 1 mM sodium pyruvate and nonessential amino acids (CellGro), 
and 0.001% 2-mercaptoethanol (Sigma). Virus isolates were laboratory strains of 
T1/Human/Ohio/Lang/1953 and T3/Human/Ohio/Dearing/1955 obtained from Max 
Nibert (Harvard University). Viruses were plaque isolated and amplified in murine 
L929 cells in Joklik's modified minimal essential medium (Gibco) supplemented with 
2% fetal bovine serum (HyClone), 2% bovine growth serum (HyClone), 2 mM 
glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (CellGro). 
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 Antibodies and reagents. Polyclonal rabbit serum against µNS has been 
previously described (2). Polyclonal rabbit anti-virion (T1L) serum was a kind gift 
from Dr. Barbara Sherry (North Carolina State University). Mouse monoclonal 
antibody (mAb) against cytochrome c was from Pharmingen. Secondary Abs were 
goat anti-mouse immunoglobulin G (IgG) and goat anti-rabbit IgG conjugated to 
Alexa 488 or Alexa 647 (Invitrogen). Etoposide (ETP) (Sigma) in DMSO was used at 
a final concentration of 100 µM, cells were incubated for 16-24 h at 37ºC after 
treatment with etoposide. 
 Infections. To determine reovirus replication in wild-type and DKO MEFs, 
cells were plated at 1-2 x 106 cells/well in a 6-well plate and incubated for 2 h to allow 
cells to adhere. Cells were infected at an MOI of 5 (determined by plaque assay on L-
cells) in 2mM MgCl2 in phosphate buffered saline (PBS) and virus was adsorbed for 1 
h at room temperature (RT). Cells were then overlayed with 2 mL/well media and 
frozen immediately (time point 0) or incubated 24-48 h. Plates were frozen/thawed 
three times, cell lysates were harvested and virus was titered on L-cells by plaque 
assay to determine pfu/mL. For cytochrome c release experiments, the TCID 50 of 
reovirus strain T3D was determined, and MEFs plated at ~5 x 105 cells/well in a 6-
well plate were incubated overnight and infected as above with TCID of 5, assuming a 
cell count of 1 x 106 cells/well. Mock infected cells were incubated with buffer only. 
Samples were processed 48 h post-infection (p. i.).  
 Transfections. Cells were plated at 4 x 105 cells/well in a 6-well plate in 
media and incubated overnight. Cells were transfected using FuGENE 6 (Roche) or 
Lipofectamine 2000 (Invitrogen) transfection reagents per manufacturer’s instructions 
and processed at 24 h post-transfection. 
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 Plasmids. The reovirus M2 gene derived from Type 1 Lang (T1L) strain was 
expressed using the mammalian expression vector pCI-neo (Promega). In-frame 
truncation mutants of T1L M2 were previously described (3).  
 Immunoblots. Cells were subcultured and grown to confluency in 10 mM 
dishes. Cells were washed in cold PBS then harvested in 50 mM Tris-HCL and 150 
mM NaCl buffer (ice cold), and resuspended in 50 mM Tris-HCl (pH 7.0), 5% 2-
mercaptoethanol (Sigma), 2% sodium dodecyl sulfate (SDS) (Acros Organics), 2.75% 
sucrose, with mini complete protease inhibitors (Roche). Aliquots were run on a 15% 
acrylamide SDS-PAGE, transferred to nitrocellulose, rinsed with water, and blocked 
with 3% non-fat dried milk in PBS at RT for 30 mins. Primary Abs were anti-Bak or 
anti-Bax (Upstate) and anti-β-actin (Sigma) in 3% non-fat dried milk in PBS overnight 
at 4ºC. Blots were rinsed in water and incubated with goat anti-rabbit IgG horse 
raddish peroxidase conjugated secondary Ab (Jackson Laboratories). Bands were 
visualized by chemiluminescence (Pierce). Image was prepared for publication using 
Photoshop and Illustrator (Adobe). 
 Flow cytometry. Cells were harvested using Accutase (Innovative Cell 
Technologies); supernatant and wash (with PBS) were collected also. Cytochrome c 
release was determined by first incubating the cells in ‘mitobuffer’--250 mM sucrose, 
20 mM HEPES (pH 7.2), 10 mM KCl, 1.5 mM MgCl2, 2 mM EDTA, 8 mM 
dithiothreitol (DTT) with 150 μg/mL digitonin for 10 min at 4ºC to permeabilize the 
plasma membrane only (4). Cells were then fixed with 1.85% formaldehyde in PBS, 
and all membranes were permeabilized with 0.14% Triton X-100, 1.8% BSA, 10% 
NGS in PBS. Antibody incubations were carried out at room temperature for 1-3 hours 
or 4ºC overnight in PBS with 1% BSA and 0.1% Triton X-100 (PBSA-T). After 
antibody incubations, cells were washed in PBS then resuspended in 1% 
paraformaldehyde in PBS. Flow cytometry data was collected with a FACSCalibur™ 
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(BD) and analyzed with CellQuest™ (BD) and FlowJo (Tree Star, Inc.) software. Data 




Validation of phenotypes. I confirmed that that the single knockout and DKO 
MEFs had the appropriate phenotypes by immunoblotting. The signal for Bax was 
weak, but was visible for both the wild type and Bak-/- MEFs (Fig. 3.1, left hand blot), 
whereas Bax-/- and wild-type MEFs both expressed Bak (Fig. 3.1, right hand blot). I 
also validated the response of wild-type cells and DKO cells to apoptotic stimuli. 
Previous studies have shown that DKO cells do not respond to apoptotic stimuli that 
activate the intrinsic apoptotic pathway, and therefore, do not release cytochrome c 
from mitochondria (14). In this experiment, wild-type cells and DKO cells were left 
untreated or treated with ETP for ~16 h. Cells were harvested (including supernatant), 
plasma membranes permeabilized, fixed, and immunostained for cytochrome c. 
Untreated wild-type cells stained positively indicating that cytochrome c was retained 
within the mitochondrial intermembrane space. Upon ETP treatment, cytochrome c 
was released as indicated by the loss of staining (peak shifted to the left). In contrast, 
DKO MEFs, which were incubated with ETP, maintained positive staining indicating 
that cytochrome c was not released from mitochondria in these cells in response to 
ETP (Fig. 3.2). 
Wild-type and Bax/Bak DKO MEFs support reovirus infection. In order to 
determine if reovirus strains T3DN and T1L were capable of replicating in wild-type 
and DKO MEFs, T3DN and T1L reoviruses were inoculated onto MEFs at an MOI ~5, 
and the infected cells were either frozen at time = 0 or 24 or 48 h p.i. Reovirus titers at 





Figure 3.1. Validation of phenotypes in Bax-/-, Bak-/- and Bax/Bak DKO MEFs. Cell 
lysates from wild-type (w/t), Bak-/- (Bak KO), Bax-/- (Bax KO) and DKO (DKO) cells 
were resuspended in 50 mM Tris-HCl buffer (pH 7.0) containing 5% β-
mercaptoethanol, 2% SDS, and 2.75% sucrose with protease inhibitors. The same 
volume per sample was loaded onto a 15% acrylamide SDS-PAGE, then transferred to 
nitrocellulose, and blotted with anti-Bax (left hand blot) or anti-Bak (right hand blot) 
and anti-β-actin primary Abs followed by goat anti-rabbit IgG and/or goat anti-mouse 





Figure 3.2. DKO MEFs do not release cytochrome c into the cytosol in response to 
ETP treatment. Wild-type (w/t) or Bax/Bak DKO MEFs were incubated with or 
without 100 µM ETP for ~16 h. Cells (including supernatant) were harvested, 
incubated in mitobuffer with digitonin, then fixed and immunostained using anti-
cytochrome c mAb followed by goat anti-mouse IgG Alexa 488 conjugated Ab. 
10,000 cells per sample were analyzed by flow cytometry. Histogram shows overlay 
of measurement of fluorescence of cytochrome c staining.
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to approximately the same extent in both cell lines at 24 h p.i. However, at 48 h p.i., 
the T3D strain showed no increase in titer above that found at 24 h p.i. in DKO MEFs 
(Fig. 3.3). Further investigation is needed to determine why T3D stopped replicating 
after 24 h in DKO cells. It is possible that T3D has reached max titer in these cells by 
24 h p.i. Another possibility is that T3D is causing apoptosis in the DKO cells whereas 
T1L is not (12), allowing T1L reovirus to replicate to a higher titer. However, since 
T3D replicates to almost a log titer more in wild-type cells than DKO cells, this 
suggest T3D simply reached the max titer at 24 h p.i. in DKO cells. 
Reovirus T3D induces cytochrome c release in DKO MEFs. Previous 
studies have shown that reovirus infection induces release of cytochrome c into the 
cytoplasm in HEK 293 cells (6). I showed in Chapter 2 that cells expressing µ1 also 
released cytochrome c. Therefore, I hypothesized that cytochrome c release from the 
mitochondrial intermembrane space is mediated by µ1. To address the role of the 
proapoptotic Bcl-2 proteins Bax and Bak in cytochrome c release during reovirus 
infection, wild-type, Bax-/-, Bak-/- and DKO MEFs were infected with T3DN  
reovirus at a TCID 50 of ~5 for 1 h at RT; then wells were overlaid with media and 
incubated for 48 h. Negative controls were mock-infected cells and positive controls 
were incubated with ETP for 24 h. The cells were harvested, immunostained for 
cytochrome c release and for expression of the reovirus nonstructural protein µNS, 
and analyzed by flow cytometry. As illustrated in Figure 3.4, less than 20% of cells 
that were mock infected showed cytochrome c release, whereas ETP treatment 
resulted in approximately 75% of the cells releasing cytochrome c, except for the 
DKO cells, which, as expected, did not release cytochrome c from the mitochondria in 
response to ETP (less than 5% of ETP-treated DKO MEFs released cytochrome c). In 
response to reovirus infection, approximately 27-33% of infected Bak-/- and DKO cells 





Figure 3.3. Replication of reovirus in MEFs. Reovirus was tittered on L-cells, then 
inoculated onto wild-type (w/t) or DKO MEFs at an MOI ~5, adsorbed at RT for 1 h, 
incubated for indicated time points, and harvested by freeze/thaw to lyse the cells. 






Figure 3.4. Reovirus infection induces cytochrome c release in MEFs.Wild-type (w/t) 
MEFs, DKO MEFs (DKO), Bak-/- MEFs (Bak KO) and Bax-/- MEFs (Bax KO) were 
incubated with ETP for 24 h, or mock infected or infected with T3D for 48 h. 
Supernatant, wash, and cells were then harvested, plasma membranes permeabilized, 
fixed, and immunostained with anti-cytochrome c mAb and anti-µNS rabbit 
polyclonal serum followed by goat anti-mouse IgG Alexa 488 conjugated and goat 
anti-rabbit IgG Alexa 647 conjugated Abs. Samples were analyzed by flow cytometry. 
10,000 cells were collected for mock and ETP treated samples, 10,000 µNS positive 
cells were collected for T3D infected samples. Graph shows means and standard 
deviations of three replicates over at least two different experiments. 
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cells (~60-70%) released cytochrome c. This indicates that wild-type and single 
knockout cells release cytochrome c in response to apoptotic stimuli (such as ETP) 
and release cytochrome c in response to reovirus infection. Additionally, DKO cells, 
which do not respond to ETP by releasing cytochrome c, do so in response to reovirus 
infection. 
Cytochrome c release in response to transfection and µ1 expression. In this 
experiment, I examined the capacity of µ1 to induce cytochrome c release in wild-type 
and DKO MEFs. Cells were transfected with pCI-Neo (vector control), pCI-M2(1-
708) to express µ1, or pCI-M2(43-582) to express δ. Negative controls were left 
untreated or treated with ETP (DKO) for 24 h. Positive controls were treated with ETP 
(wild-type) for 24 h. Cells, including supernatant were harvested, plasma membranes 
permeabilized, fixed and immunostained for cytochrome c and µ1.  
 DKO MEFs only released cytochrome c in response to µ1 expression (~35 % 
of µ1-expressing cells), in contrast, they remained unaffected by transfection, ETP 
treatment, or δ expression (< ~10% of cells). Wild-type MEFs responded strongly to 
ETP with over 90% of cells releasing cytochrome c. However, I found that the wild-
type MEFs also released cytochrome c in response to transfection with the empty 
vector (pCI-Neo) or the vectors expressing µ1 and δ. Though a slight augmentation in 
the response is seen with µ1-expressing cells [pCI-M2(1-708)] there was little 
difference in the percentage of cells releasing cytochrome c in either µ1- or δ- 
expressing cells or cells transfected with the vector control (pCI-Neo) (Fig. 3.5 A). 
These results indicate that although ~ 30% of DKO cells respond to µ1-expression by 
releasing cytochrome c, approximately the same percent of wild-type cells respond to 
µ1-expression, δ-expression, and transfection by releasing cytochrome c (Fig. 3.5 A). 
 The Bax-/- or Bak-/- MEFs also responded strongly to ETP treatment, with 70-
80% of cells showing cytochrome c release. Similar to the wild type MEFs, I found 
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that the Bax-/- cells released cytochrome c after transfection of control (pCI-Neo) as 
well as µ1 and δ-expressing plasmids with ~40% of cells releasing cytochrome c. 
However, the Bak-/- MEFs behaved more like DKO MEFs, and released cytochrome c 
in response to µ1-expression, with ~50% of µ1 positive cells releasing cytochrome c. 
Bak-/- cells showed little response to either transfection (less than 10%) or δ-
expression (~15%) induced cytochrome c release (Fig. 3.5 B). Thus, wild-type cells 
respond similarly to Bax-/- cells, and DKO cells respond similarly to Bak-/- cells, 
suggesting that Bak plays a role in cytochrome c release in response to transfection in 




In these preliminary experiments, I confirmed that wild type and Bax-/- or  
Bak-/- MEFs release cytochrome c in response to ETP, whereas DKO MEFs do not. 
Furthermore, I found that wild-type and DKO MEFs were able to support replication 
of reovirus strains T1L and T3DN, and that infection with T3DN induced cytochrome c 
release in wild type and the knockout MEFs, although to different extents. A greater 
percentage of wild-type and Bax-/- cells released cytochrome c than Bak-/- and DKO 
cells following infection with T3DN. These findings suggest that Bak is necessary for 
the augmented release of cytochrome c in response to T3DN infection, whereas Bax 
appears not to play a significant role in cytochrome c release during  
reovirus infection. Interestingly, Bax activation is associated with a loss of 
mitochondrial inner membrane potential (ΔΨm) (13) which does not occur during 
reovirus-induced apoptosis (7) and also does not occur during µ1-induced apoptosis 
(see Chapter 2). It is possible that μ1 directly interacts with Bak causing mitochondrial 
membrane permeabilization in a greater number of infected cells, or that an apoptotic 
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Figure 3.5. Cytochrome c release in response to transfection in (A) DKO and wild-
type MEFs (B) Bax-/- and Bak-/- MEFs. Cells were plated incubated overnight then 
transfected to express µ1 [pCI-M2(1-708)], δ [pCI-m2(43-582)] or vector control 
(pCI-Neo). Positive controls were treated with ETP 100 µM for 24 h, negative 
controls were untreated (x). Wild-type cells treated with ETP were used as positive 
controls for assays with DKO cells. Cells were harvested, plasma membranes 
permeabilized, fixed and then immunostained with anti-cytochrome c mouse mAb and 
anti-T1L virion rabbit serum followed by Alexa 488 or 647 conjugated goat anti-
mouse IgG or goat anti-rabbit IgG Abs. Cells were analyzed by flow cytometry. 
10,000 control or pCI-Neo transfected cells were analyzed. µ1 and δ expressing cells 
were gated on, and over 5,000 positive cells were analyzed. A) Graph shows means 
and standard deviation for three samples collected in two different experiments 







 pathway that uses Bak, but not Bax, is activated during viral infection to induce 
cytochrome c release. Also, the mechanism by which the mitochondrial outer 
membrane is permeabilized in the infected DKO MEFs remains to be determined. 
The Bak-/- and DKO cells released cytochrome c upon expression of μ1, but 
not in response to δ-expression or transfection with a control plasmid. In contrast, the 
Bax-/- and wild-type cells released cytochrome c in response to transfection alone 
suggesting that the presence of Bak sensitizes cells to transfection-induced cellular 
stress that causes cytochrome c release. Furthermore, µ1 expression did not induce 
increased levels of cytochrome c release in these cells. It is possible that the 
mechanism by which µ1 induces apoptosis is somehow blocked or compensated for in 
the wild-type and Bax-/- cells or alternatively that the background level of cytochrome 
c release associated with transfection masks any effect of μ1. It is also possible that 
these cells do not produce enough µ1 to be cytotoxic. Further studies are needed to 
evaluate caspase activation in these cells to determine if apoptosis is induced.  
DKO cells and Bak-/- cells did not show the same response to transfection and 
protein expression as the wild type or Bax-/- cells; thus implicating Bak in transfection-
induced cytochrome c release. However, µ1-expression induced cytochrome c release 
in DKO and Bax-/- cells. This finding suggests that Bax and Bak are not necessary for 
μ1-induced cytochrome c release. One possible explanation for these findings is that 
µ1 interacts directly with the mitochondrial outer membrane to cause cytochrome c 
release. Several other viral proteins have been shown to interact with mitochondria or 
proteins within the mitochondrial membranes to induce apoptosis. HIV-1 encodes a 
pro-apoptotic protein, Vpr, which cause cytochrome c release and loss of 
mitochondrial membrane potential [reviewed in (1)]. Influenza virus protein PB1-F2 
induces cytochrome c release and loss of mitochondrial membrane potential in isolated 
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mitochondria by affecting proteins in the mitochondrial permeability pore complex 
(15). 
Further studies are needed to determine the role of µ1 in cytochrome c release 
in Bax-/- and wild type MEFs. Ideally, the level of cytochrome c release in response to 
transfection should be brought to a minimum in wild type and Bax-/- cells. It may also 
prove beneficial to address the level of anti-apoptotic Bcl-2 family proteins in these 
cells to determine if they differ from the Bak-/- and DKO MEFs. Transfections in the 
presence of a broad-spectrum caspase inhibitor, Q-VD-OPh, could also provide 
additional information, as this treatment increases the steady state levels of µ1, and 
would block caspase-specific responses (see Chapter 2). This would make detection of 
µ1-expressing cells easier and more sensitive and provide data on µ1-specific as 
opposed to caspase-specific cellular events. 
I have shown that cytochrome c is released in response to T3D infection of 
MEFS. However, it is yet to be determined if reovirus infection induces apoptosis in 
these cells as cytochrome c release signals the initiation of the intrinsic apoptotic 
pathway, but not necessarily commitment to apoptosis. Furthermore, cellular 
responses may be strain specific, and this needs to be evaluated in the MEFs, as these 
cells were shown to support T1L reovirus infection as well. These preliminary data 
provide evidence that reovirus-induced cytochrome c release proceeds without Bax 
and Bak. The mechanism of cytochrome c release in the absence of Bax and Bak in 
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DEVELOPMENT OF A SINGLE CELL-BASED ASSAY TO DETECT 





Reoviruses induce apoptosis by activating the intrinsic and extrinsic apoptotic 
pathways. Previous results showed that expression of µ1 in transiently transfected 
cells causes activation of caspase-3 and nuclear changes associated with apoptosis. 
Here, the development of a flow cytometric assay to detect μ1 expression in 
transiently transfected cells is described. In addition, published flow cytometric 
techniques were modified to detect cytochrome c release from the mitochondrial 
intermembrane space in camptothecin-treated or µ1-expressing cells. Camptothecin 
treatment or transfection led to an increase in cytochrome c expression in CHO-S 
cells. Furthermore, broad spectrum caspase inhibitors partially blocked camptothecin-




 Reovirus activates both the extrinsic and intrinsic apoptotic pathways in 
infected cells (11). Early studies showed that tumor necrosis factor (TNF)-related 
apoptosis inducing ligand (TRAIL) is released from reovirus-infected cells, and 
activates death receptors on the surface of infected cells and on nearby ‘bystander’ 
cells by autocrine and paracrine mechanisms. Ligation of death receptors 4 and 5 by 
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TRAIL leads to receptor oligomerization and ultimately activation of caspase-8 
[reviewed in (21)]. Activated caspase-8 can in turn cleave caspase-3 as well as the 
Bcl-2 family protein, Bid. A cleavage fragment of Bid, tBid, re-localizes to the outer 
mitochondrial membrane where it induces oligomerization of the proapoptotic Bcl-2 
family members Bax and Bak (12). Oligomerized Bax and Bak form pores in the outer 
mitochondrial membrane which allows release of pro-apoptotic proteins such as 
cytochrome c and smac/DIABLO from the mitochondrial intermembrane space 
[reviewed in (5)]. The released cytochrome c, together with the cytosolic protein 
Apaf-1 and ATP, form a multimeric complex called the apoptosome that is responsible 
for activating caspase-9 (25). Activated caspase-9, like caspase-8, is an initiator 
caspase that can cleave and activate downstream effector caspases such as caspase-3 
and -7 (20). Cleavage of cellular substrates by effector caspases cause many of the 
morphological changes that together constitute apoptosis. Work from the Parker 
laboratory has shown that expression of the reovirus outer capsid protein µ1 induces 
apoptosis, as determined by caspase-3 activation and chromatin condensation by 
fluorescence microscopy (7). 
I hypothesized that µ1 is the primary determinant of reovirus-induced 
apoptosis. However, it is possible that µ1 is not responsible for all of the cellular 
changes associated with apoptosis that occur during reovirus infection. Therefore, an 
investigation was initiated to determine the cellular apoptotic mechanisms that are 
activated in µ1-expressing cells. In immunofluorescence microscopy experiments, 
cytochrome c was released from the mitochondria of µ1-expressing cells, but not 
control-transfected cells (see Chapter 2). However, an attempt to detect the presence 
of cytochrome c in the cytosolic fractions of pCI-M2(1-708) transfected cells by 
immunoblotting proved inconsistent as the number of cells expressing µ1 after 
transient transfection was low. Attempts to increase transfection efficiency often 
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resulted in increased apoptosis levels in the negative controls. Immunoblotting has 
been used to detect release of cytochrome c from the mitochondrial intermembrane 
space into the cytosol in reovirus-infected cells; however, in these experiments cells 
were infected with virus at high MOI (50 or 100) to ensure that all of the cells were 
simultaneously infected (11). Therefore, I wanted to ensure that my data reflected the 
cellular response to µ1 and not an artifact of transfection. Single-cell based assays that 
use flow cytometry can detect changes in a small percentage of the cell population and 
have been optimized to detect cytochrome c release from the mitochondria. Because 
flow cytometry can readily identify multiple signals from single cells, I chose to 
develop a flow cytometric assay that could detect µ1-expressing cells and assess the 
retention or release of cytochrome c in/from the mitochondria of these cells. 
Previously, the Parker laboratory has shown that µ1 is difficult to detect in 
cells on a population basis by immunoblotting due to the low steady-state levels of µ1 
expression. Therefore, adherent CHO-K1 cells were utilized to study µ1-induced 
apoptosis by immunofluorescence microscopy (7). In this study, I found that by 
modifying the protocol used for immunofluorescence microscopy, µ1 was readily 
detectable by flow cytometry in CHO-S cells which are adapted to grow in 
suspension. 
One of the first indicators of apoptosis in a cell, prior to caspase activation, is 
cytochrome c release from the mitochondrial intermembrane space (19). Several 
techniques have been used to assay cytochrome c release from the mitochondria. A 
number of studies have utilized confocal microscopy to image the localization of the 
cytochrome c inside the cell. Live cell microscopy has been performed with green 
fluorescent protein (GFP) tagged -cytochrome c, and wild-type cytochrome c has been 
immunolabeled by fixing, permeabilizing/blocking and immunostaining with anti-
cytochrome c (Clone 6H2.B4) which recognizes only the native form of cytochrome c 
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[reviewed in (9)]. Immunoblots of cytosolic and mitochondrial cellular fractions have 
also been used to determine the kinetics of cytochrome c release during reovirus-
induced apoptosis (11). In order to differentiate between the cytoplasmic or 
mitochondrial cytochrome c, the plasma membrane must be permeabilized and then 
followed by a wash step to remove the cytosolic cytochrome c; alternatively, 
subcellular fractions can be obtained [reviewed in (9)]. Flow cytometry was also used 
to measure GFP-cytochrome c release in response to UV irradiation (24). In this study, 
Waterhouse et al. used digitonin to selectively permeabilize the plasma membrane 
leaving the mitochondria intact, thereby allowing cytoplasmic cytochrome c to exit the 
cell before flow cytometry analysis.  
Here, I describe the development and optimization of a new flow cytometric 
protocol to evaluate activation of the intrinsic apoptotic pathways by detecting 
cytochrome c release in CHO-S suspensions cells expressing µ1. During the 
development of the protocol, it was found that Tween 20 and digitonin can selectively 
permeabilize the plasma membrane. Treatment of cells with camptothecin or 
transfection resulted in an increase in the expression of cytochrome c. Furthermore, 
treatment of cells with broad spectrum caspase inhibitors affected cytochrome c 
release from mitochondria. The flow cytometric protocol offers a new tool by which 
we can gain further insight into µ1-induced apoptosis. 
 
Materials and Methods 
 
 Cells. CHO-S suspension cells were grown in CHO-S-SFM II media (Gibco) 
supplemented with 100 U/ml penicillin and 100 μg/ml streptomycin (CellGro). 
Alternatively, CHO-S cells were incubated overnight in Ham’s F-12 media (CellGro) 
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supplemented with 10% fetal bovine serum (HyClone), 2 mM glutamine, 100 U/ml 
penicillin, and 100 µg/ml streptomycin (CellGro).  
 Antibodies and Reagents. Mouse monoclonal antibody (mAb) against 
cytochrome c was from Pharmingen. Mouse mAbs to reoviral protein μ1 (10F6, 10H2, 
and 4A3) have been previously described (22, 23). Polyclonal rabbit anti-virion (T1L) 
serum was a kind gift from Dr. Barbara Sherry. Secondary antibodies were goat anti-
mouse immunoglobulin G (IgG) and goat anti-rabbit IgG conjugated to Alexa 488 or 
Alexa 647 (Invitrogen); or goat anti-mouse IgG1 and IgG2a conjugated to FITC and 
APC, respectively (Jackson Labs). Broad spectrum caspase inhibitors z-VAD-fmk 
(Biomol) and Q-VD-OPh (Kamiya Biomedical Company) were resuspended in 
DMSO and used at the indicated concentrations, control cells were treated with the 
same volume of DMSO. Camptothecin (CPT) (Sigma) was dissolved in DMSO to 
make a 10 mM stock solution and used at the indicated concentrations. 4’-6-
diamidino-2-phenylindole (DAPI) (Invitrogen) was used at 0.2 µg/mL and propidium 
iodide (PI) (Sigma) was used at 50 µg/mL.  
 Plasmids. The reovirus M2 gene derived from Type 1 Lang (T1L) strain was 
expressed using the mammalian expression vector pCI-neo (Promega). In-frame 
truncation mutants of T1L were as previously described (7).  
 Transfections. CHO-S cells were resuspended at a density of 5-10 × 105 
cells/mL and transfected with FuGENE 6 (Roche) or Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions and analyzed at 24 hours (h) post-
transfection.  
 Fluorescence microscopy (IFA). CHO-S cells were plated 4 × 
105 cells/well in 6-well plates containing 18 mm glass cover slips and incubated 
overnight. Media was aspirated and cells were incubated in mitobuffer I (10 mM 
Hepes Buffer pH 7.4, 125 mM sucrose, 65 mM KCL, 0.5 mM EDTA, 1 mM MgCl2, 2 
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mM KPO4, 0.1% NaN3, and 2% BSA) [adapted from (6)] containing either 1.0% 
Tween 20 or 0.15% Triton X-100 for 15 mins at room temperature (RT). Cells were 
incubated with DAPI and PI for 15 mins at RT.  Cover slips were mounted with 
Prolong Antifade Reagent (Molecular Probes). Cells were viewed using a Nikon 
TE2000 inverted microscope equipped with fluorescence and phase optics through a 
60× 1.4 NA oil objective with 1.5× optical zoom. Digital images were captured with a 
Coolsnap HQ charge-coupled-device camera (Roper) and Openlab software 
(Improvision). Pictures were prepared using Photoshop and Illustrator (Adobe). 
 Flow cytometry. Figure 4.1 depicts the protocols used to detect cytochrome c 
release. Cells were fixed for 20 mins on ice with 2% paraformaldehyde in PBS; 1.85% 
formaldehyde in PBS (pH 7.2-7.4); or by diluting 37% formaldehyde 1:20 into media. 
Cells were then permeabilized with 0.2% Tween 20 in PBS. Alternatively, cells were 
permeabilized before fixation with 0.4% -1.5% Tween 20 in mitobuffer I at room 
temperature for 30 mins or with 150 µg/mL digitonin in mitobuffer II (20 mM Hepes 
buffer pH 7.4, 250 mM sucrose, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, and 8mM 
DTT) [adapted from (10)] at 4ºC for 10 mins; fixed as above; and then permeabilized 
with 0.15% Triton X-100 in PBS with 2% BSA for 15 mins over ice. Antibody 
incubations were carried out in PBS with 0.1% NaN3 and 2% BSA with or without 
0.1% Triton X-100 at 4ºC or RT for 45 mins. For optimal detection of µ1, 5-10% 
normal goat serum (Vector) was added to the permeabilization buffer and solutions 
used for primary Ab incubations. Cells were washed with PBS or PBS with 0.1% 
Tween 20. Cells were resuspended in PBS or PBS with 1% paraformaldehyde for flow 
cytometry analysis. Analysis was performed using a FACSCalibur flow cytometer 
(BD) with Cell Quest (BD) software. Images were prepared using FlowJo (Tree Star, 





Figure 4.1. Flow chart showing the different permeabilization methods used to 
confirm cytochrome c release by flow cytometry. A) Permeabilization of the plasma 
membrane was performed in either mitobuffer I or II. This protocol was used to detect 
cytochrome that was retained inside the mitochondria. Cytochrome c in the cytoplasm 
of the cell would be lost upon plasma membrane permeabilization. B) 
Permeabilization with Triton X-100 was performed in PBS. This protocol was used to 
detect total cytochrome c inside the cell. C) Permeabilization with Tween 20 was 
performed in PBS. In this protocol, cytochrome c staining differed based on 
cytochrome c location at time of fixation. Cytochrome c in the cytoplasm would be 
detected whereas cytochrome c inside the mitochondria was not. Immunostaining was 




Immunofluorescent staining and detection of µ1 expression by flow 
cytometry. Detection of µ1 expression from transiently transfected cells by 
immunofluorescence microscopy and immunoblot has been previously reported by the 
Parker laboratory (7); however detection has not been tried by flow cytometry. By 
modifying protocols that were previously developed for fluorescence microscopy 
(IFA), µ1 could be detected in 10-50% of transfected CHO-S cells by flow cytometry, 
comparable to IFA, using either an anti-T1L virion rabbit serum or a mixture of four 
anti-μ1 mouse mAbs (Fig. 4.2 and data not shown [see methods]).  
Detection of mitochondrial cytochrome c release by flow cytometry. 
Activation of the intrinsic apoptotic pathway in cells leads to release of cytochrome c 
from the mitochondrial intermembrane space into the cytoplasm (13, 25). Because of 
the difficulty in attaining high levels of μ1 expression, detecting cytochrome c release 
biochemically proved unreliable. Therefore, I sought to optimize detection of 
cytochrome c release on a single cell basis by flow cytometry. The principal of this 
technique is that cells which have released their mitochondrial cytochrome c into the 
cytoplasm can be distinguished from normal cells by selectively permeabilizing the 
plasma membrane prior to fixation and immunostaining for cytochrome c. In cells that 
have cytosolic cytochrome c, the selective permeabilization of the plasma membrane 
allows the cytochrome c to be washed out of the cell [reviewed in (9)]. Thus, a 
decrease in the fluorescent signal (a left-shifted peak) associated with cytochrome c 
staining indicates its release from mitochondria. Figure 4.3 illustrates the fate of 
cytochrome c in normal cells and apoptotic cells and the effects of different detergents 








Figure 4.2. Detection of µ1 expression in transiently transfected CHO-S cells by flow 
cytometry. CHO-S cells were transfected with pCI-Neo (vector control) or pCI-M2(1-
708) to express µ1. 24 h post-transfection cells were fixed, permeabilized and stained 
with anti-T1L virion rabbit serum to detect µ1 followed by goat anti-rabbit IgG Alexa 
647 conjugated. Isotype control cells were processed as above and immunostained 
with pre-bleed rabbit serum followed by secondary Ab. The total population of cells is 
shown; at least 10,000 cells were analyzed per sample. 
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Figure 4.3. Diagram illustrates response of normal or apoptotic cells to different 
detergents. Both normal and apoptotic cells should have an intact plasma membrane. 
Incubation with mitobuffer does not affect the plasma membrane; therefore 
cytochrome c (green dots) is retained in normal and apoptotic cells. Incubation with 
Tween 20 or digitonin selectively permeabilizes the plasma membrane. Cytochrome c 
will be retained in the mitochondria in a normal cell; however, in apoptotic cells, 
cytochrome c that has been released into the cytoplasm will be washed out following 
selective membrane permeabilization. Triton X-100 permeabilizes the plasma 
membrane and mitochondrial membranes; therefore, normal and apoptotic cells will 




In a pilot experiment, cells were incubated with two membrane-impermeant 
dyes, PI and DAPI. PI is a fluorescent dye that intercalates between bases and will 
form complexes with double-stranded DNA or RNA. In contrast, DAPI is a highly 
DNA-selective dye showing an A-T base preference (18). Permeabilization of cells 
with 0.2-2.0% Tween 20 left the plasma membrane partially intact with reasonable 
maintenance of cell morphology and visible cytoplasm as indicated by the PI staining 
in both the nucleus and cytoplasm (presumably associated with mitochondria or 
mRNA). In contrast treatment with 0.1-0.15% Triton X-100 removed the plasma 
membrane and the cytoplasm, as illustrated by the colocalization of PI and DAPI only 
in the nucleus and lack of cytosol in the phase contrast image (Fig. 4.4 and data not 
shown). Control cells that were incubated in mitobuffer I without detergents were PI 
and DAPI negative (data not shown). I concluded from this experiment that membrane 
permeabilization of CHO-S cells with Tween 20, in contrast to Triton X-100, 
permeabilized the plasma membrane yet maintained the gross morphology of the cell.  
In order to detect cytochrome c release from the mitochondria by flow 
cytometry, my goal was to permeabilize the plasma membrane of the cell, but leave 
the mitochondrial membrane intact. Therefore, I determined if there was a difference 
in cytochrome c staining between normal and apoptotic cells that were permeabilized 
with 0.15% Triton X-100 before fixation and cells that were permeabilized only after 
fixation. CHO-S cells were treated with camptothecin (CPT), which induces apoptosis 
and cytochrome c release (15), or DMSO (solvent only). I found that in cells that were 
permeabilized with Triton X-100 prior to fixation, no cytochrome c was detected (Fig. 
4.5 dashed lines). However, in cells that were permeabilized only after fixation, 
cytochrome c-specific staining was detected in both DMSO and CPT-treated cells 
(Fig. 4.5 solid lines). I conclude from these results that permeabilization of CHO-S 





Figure 4.4. Fluorescent staining of CHO-S cells treated with different detergents. 
CHO-S cells were incubated to adhere to cover slips. Cells were then incubated in 
mitobuffer I with indicated detergent (bottom left corner). PI (red) and DAPI (blue) 
were added and cover slips were then mounted. Left panels show overlay of two 






Figure 4.5. Cytochrome c release in response to incubation with or without Triton X-
100. CHO-S cells were treated with 10 µM CPT or an equivalent volume of DMSO. 
After 24 h cells were incubated with mitobuffer I with (dashed lines) or without (solid 
lines) 0.15% Triton X-100. Cells were then fixed, all membranes permeabilized with 
Triton X-100, and immunostained with anti-cytochrome c followed by goat anti-
mouse IgG Alexa 488 conjugated secondary Ab. Isotype controls were incubated with 
non-specific primary antibody and the same secondary Ab as experimental samples. 
Analysis was performed by flow cytometry on 10,000 cells per sample.  
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cytochrome c signal; most likely, given my findings in Figure 4.4, because the 
mitochondrial membranes were lysed and/or mitochondria were lost from the cell due 
to Triton X-100 treatment. Furthermore, there appeared to be increased expression of 
cytochrome c in cells treated with CPT. This data is investigated later in this chapter. 
My next goal was to permeabilize the plasma membrane to allow cytosolic 
cytochrome c to be washed out prior to fixation, but to retain the integrity of the 
mitochondrial outer membrane. To achieve this goal, the plasma membrane of CHO-S 
cells was selectively permeabilized with 0.4%-0.5% Tween 20 in mitobuffer I for 20-
60 mins at RT prior to fixation (see Fig 4.1 A). Cells treated with DMSO showed a 
single population that was positive for cytochrome c. However, CPT-treated cells had 
two populations that represented cytochrome c positive and negative populations (Fig. 
4.6). My interpretation of these findings is that cytochrome c retained in the 
mitochondria of DMSO-treated cells was unaffected by permeabilization with Tween 
20 prior to fixation and immunostaining; however, in a population of cells treated with 
CPT, cytochrome c that was released from the mitochondrial intermembrane space 
into the cytoplasm was washed out following selective permeabilization of the plasma 
membrane with Tween 20 prior to fixation. In this experiment I found that 
approximately 10% of DMSO-treated cells released cytochrome c from mitochondria, 
whereas over 55% of CPT-treated cells released cytochrome c. In a follow-up 
experiment, CHO-S cells incubated with DMSO or CPT for 24 h, and then 
permeabilized with different concentrations of Tween 20 from 0.5% up to 2.0%. I 
found that, similar to the results shown in Figure 4.6, all of these concentrations of 
Tween 20 allowed discrimination of cells that had released cytochrome c into the 
cytoplasm from cells that had not (data not shown).   
Other authors used 4-12 µg/mL of digitonin in ‘mitobuffer I’ to selectively 




Figure 4.6. Detection of CPT-induced cytochrome c release from the mitochondria. 
CHO-S cells were treated with 10 µM CPT or an equivalent volume of DMSO. After 
24 h, cells were processed as in Fig 4.1 A. The plasma membranes of the cells were  
permeabilized with Tween 20, cells were then fixed, all membranes were 
permeabilized with Triton X-100, and immunostained with anti-cytochrome c 
followed by goat anti-mouse IgG Alexa 488 conjugated secondary Ab. Isotype 
controls were processed as above and incubated with non-specific primary Ab 
followed by the same secondary Ab as experimental samples. Analysis was performed 
by flow cytometry on 10,000 cells per sample.  
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studies I carried out using concentrations up to 30 µg/mL of digitonin did not 
permeabilize the plasma membrane of CHO-S cells. Therefore, I tried a different 
published protocol using 150 μg/mL digitonin in a buffer similar to ‘mitobuffer II’ 
[see (10) and materials and methods] and obtained results similar to those obtained 
above with Tween 20. Approximately 40% of CPT-treated cells showed cytochrome c 
release with this plasma membrane permeabilization method (Fig. 4.7). In conclusion, 
Tween 20 or digitonin can be used to selectively permeabilize the plasma membrane 
of CPT or control-treated CHO-S cells without compromising the mitochondrial 
membrane. Therefore, this technique can be used to assay cytochrome c release from 
or retention in the mitochondrial intermembrane space. 
Camptothecin-induced cytochrome c release from mitochondria in 
apoptotic cells can be detected by fixation followed by permeabilization of CHO-
S cells. I showed above that flow cytometry can be used to detect cytochrome c 
release from CPT-treated cells by assaying for loss of cytochrome c staining in cells. 
The selective permeabilization of the plasma membranes allowed cytoplasmic 
cytochrome c to be washed out prior to fixation, then intracellular membranes were 
permeablized and cells were immunostained for cytochrome c. In contrast, 
cytochrome c release into the cytoplasm can be detected directly by 
immunofluorescence microscopy upon fixation and immunostaining as the location of 
cytochrome c in the cell can be visualized [see Chapter 2 and (9)]. My goal was to 
determine if fixation followed by Tween 20 selective permeabilization of the plasma 
membrane could be used in a flow cytometry protocol. The premise being that 
cytochrome c in normal cells would be sequestered in mitochondria and would be 
unavailable for binding by antibodies; however, cytochrome c in apoptotic cells would 
be in the cytoplasm, and retained there after fixation, and thus would be detectable by 




Figure 4.7. Detection of CPT-induced cytochrome c release from the mitochondria. 
CHO-S cells were sub-cultured and left untreated (x) or treated with 10 µM CPT for 
24 h. Cells were processed by permeabilization of the plasma membrane with 
digitonin, followed by fixation, permeabilization of all membranes with Triton X-100, 
and immunostained with anti-cytochrome c followed by goat anti-mouse IgG Alexa 
488 conjugated secondary Ab (see Fig. 4.1 A). Isotype controls were treated as above, 
incubated with non-specific primary Ab followed by the same secondary Ab as 







Figure 4.8. Diagram illustrates response of normal or apoptotic cells to fixation 
followed by permeabilization with Tween 20 and immunostaining. Tween 20 
permeabilizes only the plasma membrane so that cytochrome c (green dots) will not be 
detectable in normal cells as fixation will prevent the Ab from binding the cytochrome 
c that is sequestered in the mitochondria. Apoptotic cells which have released 
cytochrome c into the cytoplasm will immunostain positive for cytochrome c as the 
Ab is able to access the cytoplasmic cytochrome c. 
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with 10 µM CPT or the same volume DMSO for 24 h then fixed and permeabilized 
with 0.2% Tween 20 in PBS prior to immunostaining for cytochrome c. I found  
that DMSO-treated cells processed in this manner were not immunostained for 
cytochrome c. In contrast, I found that a population of CPT-treated cells was 
positively stained for cytochrome c as indicated by a second peak in the histogram 
(Fig. 4.9). These findings suggest that this protocol is useful for positively detecting 
cytochrome c release into the cytosol of CPT-treated cells. 
Since my ultimate goal was to detect cytochrome c release in cells expressing 
reovirus protein, I attempted to detect cytochrome c release in transiently transfected  
cells using the above protocol with DMSO and CPT-treated cells as negative and 
positive controls for cytochrome c release, respectively. Cells were transfected with 
pCI-M2(1-708) to express µ1 or pCI-M2(1-582) to express µ1δ (as a control for 
protein expression as μ1δ does not induce apoptosis [see Chapter 2 and (7)]). At 24 h 
post-transfection the cells were fixed with 2% paraformaldehyde in PBS, 
permeabilized with 0.2% Tween 20, and immunostained for cytochrome c and µ1. As 
before, I found that a subpopulation of the CPT-treated cells, stained positively for 
cytochrome c suggesting that this population of cells had released cytochrome c into 
the cytoplasm. As expected, none of the cells transfected with pCI-M2(1-582) or 
treated with DMSO stained positively for cytochrome c. Surprisingly, cells transfected 
with pCI-M2(1-708) and expressing µ1, which I expected would have released 
cytochrome c into the cytoplasm showed no clear subpopulation of cells that stained 
positively for cytochrome c (Fig. 4.10). These findings suggested that CPT treatment 
of CHO-S cells causes cytochrome c release from mitochondria, but that expression of 
µ1 or µ1δ does not; however, these findings conflicted with my immunofluorescence 
microscopy data showing cytochrome c release into the cytosol of cells expressing μ1 




Figure 4.9.  Detection of CPT-induced cytochrome c release from the mitochondria. 
CHO-S cells were treated with 10 µM CPT or an equivalent volume of DMSO for 24 
h. Cells were fixed with 2% paraformaldehyde in PBS, plasma membranes 
permeabilized with 0.2% Tween 20 in PBS (see Figs. 4.1 C and 4.8), and 
immunostained with anti-cytochrome followed by goat anti-mouse IgG Alexa 488 
conjugated secondary Ab. Isotype controls were treated as above and incubated with 
non-specific primary and the same secondary Ab as experimental samples. Analysis 







Figure 4.10. Detection of cytochrome c release in response to transfection. CHO-S 
cells were transfected with pCI-M2(1-708) to express µ1, pCI-M2(1-582) to express 
µ1δ, or treated with 10 µM CPT or an equivalent volume of DMSO. After 24 h cells 
were fixed, plasma membranes were permeabilized with Tween 20 and 
immunostained with anti-cytochrome c and anti-µ1 mouse mAb followed by goat anti-
mouse IgG1 and IgG2a conjugated to FITC and APC, respectively. Isotype controls 
were treated as above and incubated with non-specific primary Abs and the same 
secondary Abs as experimental samples. Analysis was performed by flow cytometry 
on 10,000 cells per sample. Histogram shows total population of cells.  
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Detection of cytochrome c release into the cytoplasm of µ1-expressing cells 
by flow cytometry. To investigate the reason for the difference in results obtained for 
cytochrome c release using the protocol above and immunofluorescence microscopy, I 
 assessed the total amount of cytochrome c inside CHO-S cells that were transiently 
transfected with pCI-M2(1-708) or pCI-M2(1-582) to determine if transfection or viral 
protein expression would provide an explanation for the apparent lack of cytochrome c  
release in pCI-M2(1-708) transfected cells observed by flow cytometry (Fig. 4.10). At 
24 h post-transfection cells were resuspended briefly in mitobuffer I (without 
detergent) then fixed with 2% paraformaldehyde in PBS, all membranes were 
permeabilized with 0.15% Triton X-100, and then immunostained for cytochrome c 
and µ1 (see Figure 4.3 top panel for expected results). As expected, cells treated with 
DMSO or CPT or transfected with pCI-M2(1-582) had a single population that stained 
positively for cytochrome c. There was no decrease in cytochrome c expression in the 
pCI-M2(1-582) transfected cells when compared with the DMSO or CPT-treated cells. 
Surprisingly, I found that cells that were transfected with pCI-M2(1-708) had two 
populations--one which was negative (26.7% of the population) and one which was 
positive for cytochrome c. To determine if the population of cells that was negative for 
cytochrome c expressed μ1, I gated on cells that were expressing µ1 and found that 
39.5% of µ1 expressing cells were negative for cytochrome c. This indicated that µ1-
expression was at least partly responsible for the cytochrome c negative population in 
pCI-M2(1-708) transfected cells. Gating of µ1δ-expressing cells showed that only a 
negligible percentage were cytochrome c negative (Fig. 4.11). I conclude that transient 
transfection, as with DMSO or CPT treatment, does not cause release of cytochrome c 
from cells that were fixed before permeabilization. However, transfection of pCI-
M2(1-708) appears to cause cytochrome c release, not only from the mitochondrial 




Figure 4.11. µ1 induces cytochrome c release from the cell. CHO-S cells were 
transfected with pCI-M2(1-708) to express µ1, pCI-M2(1-582) to express µ1δ, or 
treated with 10 µM CPT or equivalent volume DMSO. After 24 h, cells were 
incubated briefly in mitobuffer, fixed, all membranes permeabilized with Triton X-
100, and immunostained with anti-cytchrome c and anti-µ1 mouse mAbs followed by 
goat anti-mouse IgG1 and IgG2a conjugated to FITC and APC, respectively. Isotype 
controls were processed as above and incubated with non-specific primary Abs and 
the same secondary Abs as experimental samples. Analysis was performed by flow 
cytometry on 10,000 cells per sample. The total population of CPT and DMSO-treated 
cells are shown, only µ1- and µ1δ-expressing cells are shown for pCI-M2(1-708) [µ1] 
and pCI-M2(1-582) [µ1δ] transfected populations. 
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Transfected and camptothecin-treated CHO-S cells show increased 
mitochondrial cytochrome c levels. An increase in cytochrome c levels and  
hyperpolarization of the mitochondria has been reported in Jurkat cells treated with 10 
µM CPT. Mitochondrial levels of cytochrome c increased for the first two hours after 
CPT treatment, then decreased by 3 h post-treatment, with a corresponding increase in 
the amount of cytochrome c in the cytosolic fraction (15). This study monitored 
cytochrome c levels by immunoblot; so results were based on the total cell population. 
In my study, I monitored cytochrome c by flow cytometry, allowing for a more precise 
measurement of protein levels on a single cell basis. In one of my early experiments in 
which cells were incubated in mitobuffer, then fixed, permeabilized with Triton X-
100, and stained for cytochrome c, I noticed that compared to DMSO-treated cells, the 
geometric mean of fluorescence for cytochrome c staining was higher in CPT-treated 
cells (Fig. 4.12; see also Fig. 4.5). As fluorescence intensity directly correlates with 
protein expression levels, this data indicated that similar to Jurkat cells, CHO-S cells 
treated with camptothecin upregulated expression of cytochrome c. When CPT-treated 
cells were processed by plasma membrane permeabilization (with digitonin), fixation, 
membrane permeabilization (with Triton X-100), and immunostaining; I identified 
two populations of cells. One population, represented by the rightmost peak in the 
diagram (Fig. 4.13), similar to the population of CPT-treated cells shown in Figure 
4.12, had increased levels of cytochrome c staining when compared to the untreated 
control cells. A second population of CPT-treated cells had a lower level of 
cytochrome c expression, representing CPT-treated cells that have released 
cytochrome c from their mitochondria.   
Next, I compared the expression levels of cytochrome c in a population of 
transfected cells to those of untreated controls. There was a slight increase in the 




Figure 4.12. CPT induces increased expression of cytochrome c in CHO-S cells. Cells 
were treated with 10 µM CPT or equivalent volume DMSO for 24 h. Cells were 
incubated in mitobuffer, fixed, all membranes permeabilized with Triton X-100, and 
immunostained with anti-cytochrome c followed by goat anti-mouse IgG conjugated 
to Alexa 488. Isotype controls were treated as above and incubated with non-specific 
primary Ab followed by the same secondary Ab as experimental samples. Analysis 





Figure 4.13. CPT induces increased expression of cytochrome c in the mitochondria. 
CHO-S cells were sub-cultured and left untreated (x) or treated with 20 µM CPT for 
24 h. Cells were processed by plasma membrane permeabilization with digitonin, 
fixed, permeabilization of all membranes with Triton X-100, and immunostained with 
anti-cytochrome c followed by goat anti-mouse IgG conjugated to Alexa 488. Isotype 
controls were treated as above and incubated with a non-specific primary Ab followed 
by the same secondary Ab as experimental samples. Analysis was performed by flow 




Figure 4.14. Transfection induces upregulation of cytochrome c in the mitochondria. 
CHO-S cells were transfected with pCI-M2(1-708) to express µ1, pCI-M2(43-582) to 
express δ, or vector control (pCI-Neo). After 24 h, cells were processed by plasma 
membrane permeabilization with digitonin, fixed, permeabilization of all membranes 
with Triton X-100, and immunostained with anti-cytochrome c and anti-µ1 mouse 
mAb followed by goat anti-mouse IgG1 and IgG2a conjugated to FITC and APC, 
respectively. Isotype controls were transfected with vector control (pCI-Neo), treated 
as above and incubated with a non-specific mouse IgG1 Ab and anti-µ1, followed by 
the same secondary Abs as experimental samples. Analysis was performed by flow 
cytometry on at least 10,000 cells per sample. Total populations are shown.
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in mean fluorescence was not as prominent as that seen in CPT-treated cells. To 
quantify these differences, I averaged the geometric means of the cytochrome c 
positive populations and deducted the average of the geometric means of the control 
samples from at least three independent experiments (Fig. 4.15). From this analysis I 
found that CPT-treatment increased the geometric mean of fluorescence for 
cytochrome c dramatically over control levels. I also found a subtle but consistent 
increase in mitochondrial cytochrome c levels is induced by transfection. This 
response did not appear to be specific to expression of a particular protein because 
cells transfected with the vector control, pCI-Neo, had similar cytochrome c levels as 
cells transfected with either pCI-M2(1-708) or pCI-M2(43-582). 
Broad spectrum caspase inhibitors z-VAD-fmk and Q-VD-OPh inhibit 
some but not all cytochrome c release induced by camptothecin and high levels of 
DMSO. Camptothecin, a quinoline alkaloid, binds to DNA and topoisomerase I 
preventing DNA re-ligation and inducing apoptosis (1). In 2000, a study by Sánchez-
Alcázar, et al. reported that mitochondrial events, including cytochrome c release 
preceded caspase activation in Jurkat cells that were treated with CPT, and that 
cytochrome c release was not inhibited by pretreatment with the broad spectrum 
caspase inhibitor z-VAD-fmk (15). In contrast, a study in H-460 cells showed that 
nuclear events including caspase-3 and -7 activation occurred before mitochondrial 
events following CPT treatment (14).  These authors found that z-VAD-fmk prevented 
apoptosis; however, they did not determine if z-VAD-fmk affected cytochrome c 
release from the mitochondria (14).  
To determine if broad spectrum caspase inhibitors prevented cytochrome c 
release in our system, CHO-S cells were treated with 10 µM CPT or an equal volume 
of DMSO (1:1000), together with 50 µM z-VAD-fmk or the same volume of DMSO 




Figure 4.15. Change in mean fluorescent channel (MFC) of cytochrome c 
fluorescence. The average geometric mean of cytochrome c positive cells for untreated 
cells was subtracted from the average geometric mean of the cytochrome c positive 
population in the experimental samples. This difference in geometric mean is plotted 
in the graph. Error bars show standard error. 
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20, and stained for cytochrome c (see Fig. 4.8 for clarification). Unlike previous 
experiments in which the DMSO-treated control cells showed a single peak in the first 
decade and CPT-treated cells showed two peaks, spanning decades one and two (see 
Fig. 4.5), the DMSO control cells showed a broad peak spanning the first decade and 
half of the second decade. Additionally, the z-VAD-fmk treated DMSO cells showed a 
second peak in the second decade. The CPT plus DMSO-treated cells showed a peak 
in the first and second decade, as expected. The CPT plus z-VAD-fmk-treated cells 
showed a decrease in the peak in the second decade with a corresponding increase in 
the peak in the first decade (Fig. 4.16).  From this experiment, I concluded that 50 µM 
z-VAD-fmk decreased the percent of cells with cytochrome c release caused by CPT. 
However, the addition of the 1:200 dilution DMSO, intended as a control for z-VAD-
fmk treatment appeared to induce a low, but noticeable, release of cytochrome c, 
which also occurred in the z-VAD-fmk plus DMSO treated cells. Whether the latter is 
attributable to z-VAD-fmk or the DMSO carrier is unknown.  
To determine if this was a dose-specific response, the concentration of z-VAD-
fmk was increased to 100 µM per sample, with DMSO added at 1:100 as a control. 
Unlike previous experiments, cells treated with CPT plus 1:100 DMSO show a right 
shifted peak into the second and third decades, indicating that the majority of cells 
have released cytochrome c from the mitochondria. Furthermore, cells treated with 
1:1000 plus 1:100 DMSO showed a peak in the second decade, indicating that the 
majority of cells have also released cytochrome c (Fig. 4.17). Cells treated with 
1:1000 DMSO plus 100 µM z-VAD-fmk showed a peak in the first decade that has a 
shoulder leading into the second decade, indicating that this concentration of z-VAD-
fmk prevents the majority of cells from releasing cytochrome c in response to a high 
concentration of DMSO. 100 µM z-VAD-fmk also prevented some cells from 




Figure 4.16. Affect of broad-spectrum caspase inhibitors on CPT induced cytochrome 
c release. CHO-S cells were treated with 10 µM CPT or the same volume DMSO 
(1:1000), and 50 µM z-VAD-fmk or the same volume DMSO (1:200). After 24 h, 
cells were fixed, plasma membranes permeabilized with Tween 20 (see Figs. 4.1C and 
4.8), and immunostained with anti-cytochrome c followed by goat anti-mouse IgG 
conjugated to Alexa 488. Isotype control was processed as above and incubated with 
non-specific primary Ab and the same secondary Ab as experimental samples. 







Figure 4.17. Inhibition of broad-spectrum caspase inhibitors on CPT-induced 
cytochrome c release. CHO-S cells were treated with 10 µM CPT or the same volume 
DMSO (1:1000), and 100 µM z-VAD-fmk or the same volume DMSO (1:100). After 
24 h, cells were fixed, plasma membranes permeabilized with Tween 20 (see Figs. 
4.1C and 4.8), and immunostained with anti-cytochrome c followed by goat anti-
mouse IgG conjugated to Alexa 488. Isotype control was processed as above and 
incubated with non-specific primary Ab and the same secondary Ab as experimental 
samples.
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decade and the smaller peak in the second decade. These data indicate that high levels 
of DMSO (1:100) induce cytochrome c release in cells, but this can be partially 
blocked by 100 µM z-VAD-fmk. This level of z-VAD-fmk is also somewhat 
protective of CPT induced cytochrome c release; however at this level, z-VAD-fmk 
may be inhibiting other cellular responses, such as cathepsins, non-specifically (16). 
To circumvent the issue of cytochrome c release due to high concentrations of 
DMSO and non-specific side effects of z-VAD-fmk, I switched to using the broad 
spectrum caspase inhibitor Q-VD-OPh at concentrations of 10 µM (1:1000) or 20 µM  
 (1:500). In these experiments, cells were treated with 20 µM CPT for 24 h. 20 µM Q- 
VD-OPh was added at the same time as CPT. Cells were permeabilized with 150 
µg/mL digitonin in mitobuffer, then fixed; all membranes were permeabilized with 
Triton X-100, and immunostained for cytochrome c (see Fig. 4.1A for clarification). 
Untreated cells showed a single peak in the second decade indicating that cytochrome 
c was retained in the mitochondria whereas CPT-treated cells showed two peaks. The 
right-most peak representing cells that had retained cytochrome c in their 
mitochondria and the left-most peak indicating a population of cells that had released 
cytochrome c. However, when cells were treated with Q-VD-OPh at the same time as 
CPT, fewer cells released cytochrome c from the mitochondria (Fig. 4.18). This 
suggests that Q-VD-OPh prevented some cells from releasing cytochrome c in 
response to CPT. This data was quantified and, as shown in Figure 4.19, the average 
percentage of CPT-treated cells with cytochrome c release as determined by flow 
cytometry decreased following treatment with Q-VD-OPh. The addition of Q-VD-
OPh to untreated cells tended to increase the percentage of cells showing cytochrome 
c release. Noticeably, untreated cells and CPT-treated cells incubated with Q-VD-OPh 




Figure 4.18. Effect of broad-spectrum caspase inhibitors on CPT induced cytochrome 
c release. CHO-S cells were sub-cultured and treated with 20 µM CPT, 20 µM CPT 
plus 20 µM Q-VD-OPh, or left untreated (x). After 24 h plasma membranes were 
permeabilized with digitonin, then cells were fixed, all membranes were  
permeabilized with Triton X-100 and immunostained with anti-cytochrome c followed 
by goat anti-mouse IgG Alexa 488 conjugated secondary Ab. Isotype controls were 
processed as above and incubated in a non-specific primary Ab and the same 
secondary Ab as experiemental samples. Analysis was performed by flow cytometry 






Figure 4.19. Effect of broad-spectrum caspase inhibitors on cytochrome c release. 
CHO-S cells were subcultured and left untreated or incubated for 24 h with either 20 
µM Q-VD-OPh, 20 µM CPT, or 20 µM Q-VD-OPh plus 20 µM CPT. Plasma 
membranes were permeabilized with digitonin, then cells were fixed, all membranes 
permeabilized with Triton X-100 and immunostained for cytochrome c. 10,000 cells 
were analyzed by flow cytometry. Graph shows the means of two (untreated plus Q-
VD-OPh) or three independent experiments (untreated, CPT, CPT plus Q-VD-OPh).  
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OPh inhibited cytochrome c release in CPT-treated cells and may be slightly toxic to 




 In this study, I successfully detected µ1 expression in transiently transfected 
cells by flow cytometry. I found that optimal detection of μ1 was dependent upon cells 
of low passage number that were subconfluent (in log phase growth) at the time of 
transfection, and that the transfection reagents and DNA were of the highest quality. 
Flow cytometry is advantageous in that the entire population of transfected cells can 
be monitored and the µ1-expressing cells can be isolated by gating and further 
analyzed for other phenotypes. 
 In addition to optimizing the detection of µ1 by flow cytometry, I also 
optimized a protocol for detection of cytochrome c release that can be used in  
conjunction with immunolabeling of µ1. I found that the optimal protocol for 
detecting cytochrome c release following pCI-M2(1-708) transfection of CHO-S cells 
required selective permeabilization of the plasma membrane with digitonin or Tween 
20. This allowed any cytochrome c that had been released from the mitochondrial 
intermembrane space into the cytosol to be released from the cell. The cells were then 
fixed, all membranes permeabilized with Triton X-100, and immunostained for 
cytochrome c and µ1. 
Another method that I tried was one in which cells were fixed, permeabilized 
with Tween 20, and immunostained for cytochrome c and µ1. This method was able to 
detect differences in cytochrome c staining patterns between CPT- and DMSO-treated 
cells. I speculate that by using Tween 20, only the plasma membrane of the fixed cells 
was permeabilized such that only cytoplasmic cytochrome c was detected upon 
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immunostaining (see Fig. 4.8). However, using this protocol I could not detect 
cytochrome c release in µ1-expressing cells. Based on the above data (see Fig. 4.14) 
and subsequent experiments performed, I believe that the cells released cytochrome c 
completely from the cell as a consequence of µ1-induced permeabilization of the 
plasma membrane preventing detection of cytochrome c by this method (see Chapter 
2). 
 Digitonin has been widely used to selectively permeabilize the plasma 
membrane of cells to study cytochrome c release [reviewed in (9)]. This nonionic 
detergent complexes with cholesterol in the membrane facilitating its 
permeabilization, and it is thought that the relative lack of cholesterol in the outer 
mitochondrial membranes accounts for this differential or selective permeabilization 
of the plasma membrane without disruption of the outer mitochondrial membrane (6, 
17). Differences in cholesterol content in the plasma membrane among cell lines may 
also be the reason that concentrations of digitonin used to permeabilize HL-60 cells or 
thymocytes did not work in CHO-S cells (6, 10). 
 Unlike digitonin, Tween 20 is not recognized for its selective membrane 
permeabilization properties. Commonly, Tween 20 is used to disrupt protein-protein 
interactions, and is useful in permeabilizing fixed cells for intracellular antigen 
detection. In this capacity, Tween 20 is often used after an aldehyde fixative which 
causes cross-linking of the cellular membrane proteins (8). In experiments where I 
fixed cells and then permeabilized with Tween 20, I found that mitochondrial 
cytochrome c was not detected after immunostaining. A plausible explanation for this 
observation is that Tween 20, in contrast to Triton X-100, did not permeabilize the 
mitochondrial membrane after paraformaldehyde fixation, and thus antibodies could 
not access the mitochondrial intermembrane space. Also, I found that Tween 20 could 
selectively permeabilize the plasma membrane before fixation of CHO-S cells without 
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disrupting the outer mitochondrial membrane (see Fig. 4.6). Although there is no 
precedence for this property of Tween 20, 1.0% Tween 80 has been used to 
permeabilize CHO cells without affecting DNA synthesis or gross morphology and 
decreasing viability by only ~20% (4), indicating that the mitochondria stayed 
relatively intact in these cells. Both Tween 20 and Tween 80 have 20 oxyethylene 
groups; however Tween 20 contains lauric acid, which has a saturated hydrocarbon 
chain, whereas Tween 80 contains oleic acid, which has a monounsaturated 
hydrocarbon chain, as the fatty acid component [reviewed in (2, 3)]. Therefore, it is 
likely that Tween 20 and Tween 80 interact similarly with cellular membranes. 
Though not conclusive, my data suggests that Tween 20 can be used to selectively 
permeabilize the plasma membrane and this warrants further investigation, as it may 
prove helpful in future studies of  intracellular organelles. 
 Camptothecin performed as expected and continues to be the positive control 
of my choice in apoptosis studies. Curiously, how apoptotic pathways are activated by 
CPT remains largely unknown. One possibility is that apoptosis occurs secondary to 
DNA damage (15). My findings suggest that caspase activation is necessary for the 
full effects of apoptosis to be seen in CPT-treated CHO-S cells, as treatment with a 
broad spectrum caspase inhibitor concurrently with CPT partially blocked cytochrome 
c release (see Figs. 4.17-19).  
I found that cytochrome c expression was increased in the entire population of 
CPT-treated CHO-S cells (see Figs. 4.11 and 4.12). My analysis of CPT-treated cells 
also indicated that some of these cells had not released cytochrome c from 
mitochondria (see Fig. 4.13). These findings indicate that increased expression of 
cytochrome c and release of cytochrome c from the mitochondrial intermembrane 
space are independent events in CHO-S cells. Increased cytochrome c expression also 
occurred in transfected cells independently of whether those cells expressed viral 
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protein or not. As with CPT-treated cells, cytochrome c expression increased in the 
total population yet only a sub-population of µ1-expressing cells showed release of 
cytochrome c from the cell (see Fig. 4.11). Therefore, upregulation of cytochrome c 
may be a non-specific cellular stress response which could be investigated further by 
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FORMATION OF REOVIRUS OUTER CAPSID PROTEIN µ1 INTO RING-LIKE 





Three serotypes of mammalian orthoreoviruses have been isolated from humans:  
type1, type 2, and type 3. Prototype viruses of each of the serotypes are commonly 
used in experiments and include strains Type 1 Lang (T1L) and Type 3 Dearing 
(T3D). Reassortant viruses have been made by co-infection of L-cells with two viral 
strains and harvesting, then genotyping, the progeny virions. In this study, a panel of 
T1L × T3D reassortant viruses were used to map a strain-dependent difference in the 
localization of outer capsid protein µ1 to ring-like structures in infected cells. µ1, 
encoded by the M2 genome segment, is known to interact with another outer capsid 
protein, σ3, and potentially interacts with inner capsid proteins λ2 and/or σ2 during 
virion assembly. I found that the strain differences in the observable staining pattern of 




 Three distinct strains of nonfusogenic mammalian orthoreoviruses (reoviruses) 
have been isolated from children: Type 1 Lang (T1L), Type 2 Jones (T2J), and Type 3 
Dearing (T3D).  T2J and T3D were isolated from children with diarrhea. An additional 
type 3 strain, Abney (T3A), was isolated from a child with an upper respiratory illness. 
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Despite being isolated from children with clinical symptoms, no strain of reovirus has 
been definitively linked with disease in humans. However, reoviruses have been 
shown to induce apoptosis in vivo and in vitro (11) and to be oncolytic [reviewed in 
(16)], with type 3 inducing the highest levels of apoptosis (17). The three serotypes are 
defined by neutralization tests; anti-serum against a specific serotype will not 
neutralize reoviruses of different serotypes. Also, hemagglutination-inhibition tests are 
used to define serotypes, as only type 3 serotypes agglutinate bovine red blood cells. 
Neutralization and hemagglutination abilities have been linked to the S1 genome 
segment, and are attributed to the structural protein σ1 (14, 19).   
The above strains of reovirus are prototypes and are propagated in mouse L 
929 fibroblast cells for laboratory use.  Co-infections of cell cultures or mice with 
more than one reovirus strain results in virions which contain genome segments 
derived from different parents termed reassortant viruses (14). Reassortant viruses can 
be genotyped by separating the double stranded RNA (dsRNA) genome segments 
using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). 
Genome segment migration rates differ among the serotypes and therefore each 
genome segment can be identified as arising from a specific parental serotype (19).  
A number of studies utilizing panels of reassortant viruses have been done in 
order to link phenotypic differences between two viral strains to specific genome 
segments and the encoded proteins. One study showed that the M2 genome segment, 
which encodes the outer capsid protein µ1, was the major determinant of virulence in 
neonatal mice inoculated perorally, and that this is attributable to differences between 
type 1 and 3 in the susceptibility of the µ1 protein to cleavage by chymotrypsin (8, 
13). A recent study also linked the differences in apoptosis induction by different 
reovirus strains to the M2 genome segment (6). However, the amino acid sequence of 
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µ1 is highly conserved, with less than 3.5% residues differing among the serotypes 
(20). 
Reoviruses have a double layered protein coat. The outer capsid surrounds an 
inner capsid, or core, which encases the ten dsRNA genome segments. In order for the 
outer capsid of reovirus virions to form, µ1 must assemble with another outer capsid 
protein, σ3 (15), to form heterohexameric complexes (9). Here, I confirmed that µ1 is 
dispersed in the cytoplasm of cells infected with T1L reovirus whereas it forms ring-
like structures in cells infected with T3D at 48 hours post-infection. In this study, I 
used a panel of T1L × T3D reassortant viruses to determine that a particular µ1 
staining pattern observed by fluorescence microsopy during infection mapped only to 
the M2 genome segment.  
 
Materials and Methods 
 
 Cells and viruses. Virus isolates were laboratory strains of 
T1/Human/Ohio/Lang/1953, T3/Human/Ohio/Dearing/1955, and reassortant viruses 
made from the parental strains obtained from Max Nibert, Harvard University, created 
by Dennis Drayna and Earl Brown (Table 5.1). Viruses were plaque isolated and 
amplified in murine L929 cells in Joklik's modified minimal essential medium (Gibco) 
supplemented with 2% fetal bovine serum (HyClone), 2% bovine growth serum 
(HyClone), 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin 
(CellGro). CV-1 cells were grown in Ham’s F-12 media (CellGro) supplemented with  
10% fetal bovine serum, 100 U/ml of penicillin, 100 μg/ml streptomycin, 1 mM 
sodium pyruvate and non-essential amino acids (CellGro).  
 Antibodies and reagents. Mouse monoclonal antibody (mAb) 10F6 against 
µ1 and rabbit polyclonal serum against µNS have been previously described (2, 18). 
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Table 5.1. Genetic components of reassortant viruses. Each virus contains 10 dsRNA 
segments derived from either the T1L or T3D parent virus. ‘L’ indicates genome 
segment was derived from T1L strain, and ‘D’ indicates genome segment was derived 
from T3D strain.    
    
Clone   Genome Segments   
 L1 L2 L3 M1 M2 M3 S1 S2 S3 S4 
G16 L L L D L L L D L L 
EB113 L L L D L L L L D L 
G2 L D L L L L D L L L 
H14 L L D L L L L D D L 
EB31 L L L D L L L D D L 
EB87 L D L L D L L D L L 
EB144 L L L L D D L L D L 
EB68 L D L L D L L L D D 
H5 D D L L L D L D L D 
EB138 D L L D D L D D L L 
EB120 D D D L L D D D L L 
EB124 D D D D L D D L L L 
EB18 D D L D D D L L D L 
EB118 D D L L D D D D L L 
EB121 D D L D L D L D D D 
H15 L D D L D D D D D L 
EB129 D D D D D L D L L D 
EB136 D D D L D L D D D D 
EB62 D D D D D D D L D L 
EB28 D D L D D D D L D D 
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4',6'-diamidino-2-phenylindole (DAPI) and Prolong Antifade Reagent were from 
Invitrogen. Secondary antibodies goat anti-mouse IgG conjugated to Alexa 488 and 
goat anti-rabbit IgG conjugated to Alexa 594 were also from Invitrogen. 
 Infections. CV-1 cells were plated at a density of approximately 6 × 105 
cells/well in a 6-well plate with an 18 mm glass cover slip and incubated overnight. 
Cells were then infected at an MOI of 5 diluted in a total volume of 200 µL in 2 mM 
MgCl2 in PBS, assuming a confluent cell count of 1.2 × 106 per well. Virus was 
adsorbed on cells for one hour (h) at room temperature (RT) then 2 mL of culture 
medium/well was added. Cells were incubated at 37ºC and 5% CO2 for 48 h. 
 Fluorescence microscopy (IFA). All steps were carried out at room 
temperature. Cells were fixed for 10 mins in 2% paraformaldehyde in PBS, washed 
with PBS then permeabilized for 5 mins with PBS containing 1% bovine serum 
albumin (BSA) and 0.1% Triton X-100 (PBSA-T). Cells were then incubated with 
mouse mAb against µ1 and rabbit serum against µNS for 30-60 mins. Cover slips 
were washed three times with PBS then incubated with goat anti-rabbit IgG and goat 
anti-mouse IgG conjugated to Alexa 594 and 488, respectively, for 30 mins at RT.  
Cover slips were then stained with DAPI for 5 mins, washed three times with PBS, 
and mounted with Prolong Antifade Reagent. Cells were viewed using a Nikon 
TE2000 inverted microscope equipped with fluorescence and phase optics through a 
60× 1.4 NA oil objective with 1.5× optical zoom. Digital images were captured with a 
Coolsnap HQ charge-coupled-device camera (Roper) and Openlab software 
(Improvision). Pictures were prepared using Photoshop and Illustrator (Adobe). Cells 
that were positive for µNS and µ1 were scored.  
 Statistical Analysis. A table was prepared which listed the strains with their 
corresponding genome segments in order by rank based on mean + standard deviation 
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(S.D.) (Tables 5.1 and 5.2). This data was used to run Mann-Whitney Tests using 




 The staining pattern of µ1 in infected cells differs depending on reovirus 
strain. During infection, reovirus nonstructural protein µNS forms inclusions in the 
cytosol, termed viral factories, that are thought to be the sites of viral replication and 
assembly (3, 10). Reovirus core structural proteins are known to localize to the viral 
factories (1); however, there is little information on the distribution of outer capsid 
proteins in the cell during infection. In this study, CV-1 cells were infected with either 
T1L or T3D reovirus strains at an MOI of 5. At 48 h p.i. cells were fixed and stained 
for the nonstructural protein µNS and the structural protein µ1. In cells infected with 
either strain, µNS formed viral factory structures close to the nucleus (Figure 5.1 
middle and end panel). In cells infected with T1L strain reovirus, µ1 predominantly 
was dispersed throughout the cytoplasm of the cell (Figure 5.1 middle panel). 
However, µ1 often formed ring-like structures in proximity to viral factories in cells 
infected with T3D strain reovirus (Figure 5.1 end panel). This data clearly indicates a 
strain difference in the subcellular distribution pattern of µ1 in infected cells.   
The number of infected cells in which µ1 was observed to form ring-like 
structures varied with the genetic background of the infecting virus. To identify 
the genetic determinate(s) of the phenotypic difference in µ1 distribution in T1L and 
T3D–infected cells, the percentage of infected cells in which µ1 showed a dispersed 
staining pattern was evaluated. CV-1 cells were infected with a panel of 20 reassortant 
viruses and the parental viruses (T1L and T3D), fixed, and stained at 48 h p.i.  90% of 





Figure 5.1.  Distribution of µ1 in reovirus infected CV-1 cells at 48 h p.i. Mock 
infected or reovirus strain is specified in upper left corner. Cells were fixed, 
permeabilized, and immunostained with rabbit anti-µNS serum and anti-µ1 mAb 
followed by goat anti-rabbit IgG Alexa 594 conjugated (red color) and goat anti-
mouse IgG Alexa 488 conjugated (green color) secondary Abs. Nuclei were stained 
with DAPI (blue color). Merged images of three different channels are shown. Scale 
bars are 10 µm. 
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whereas only approximately 2% of cells infected with the reassortant virus B28 
showed µ1 in a dispersed staining pattern. Values ranged between these high and low 
values and were used to rank the 22 viruses by the average percent of cells with a 
dispersed µ1 staining pattern (Table 5.2). One parental strain, T1L, ranked 12th, with 
57% of the infected cells showing µ1 in a dispersed staining pattern. In contrast, the 
 other parental strain, T3D, ranked 17th, with approximately 26% infected cells that 
showed a dispersed µ1 staining pattern. 
 The phenotypic difference in µ1 subcellular distribution in T1L and T3D-
infected cells maps to the M2 genome segment. Reassortant and parental virus 
strains ranked as described above were analyzed using a Mann-Whitney Test. This  
determined the statistical significance of the contribution of each genome segment to 
the rank of the virus strain based on µ1 staining pattern. Table 5.3 shows the 2 tailed 
p- value of each genome segment of the entire panel of 22 viruses. Using a p<0.05 
cut off, only the M2 genome segment was statistically significant at p<0.001. 
Interestingly, the S2 genome segment was close to being statistically significant with a 
p=0.0591 value; and the S1 genome segment had a p=0.0879 value.  
Next, the panel was split, and reassortants with an M2 genome segment 
derived from T1L were analyzed separately from the viruses with a T3D derived M2 
genome segment. Eight viruses were used for each panel: H14, EB120, EB113, H5, 
EB31, G16, EB121, and T1L for the T1L derived M2 panel (Table 5.4) and: H15, 
EB136, EB87, T3D, EB118, EB138, EB144, EB129 for the T3D derived M2 panel 
(Table 5.5). The viruses were ranked as before and the contribution of each genome 
segment, with the exception of M2, to the scored phenotype was determined 
statistically by Mann-Whitney Test.  
Analysis of the viruses that possessed the M2 genome segment derived from 
the T1L parental virus showed the S1 genome segment significantly influenced the 
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Table 5.2.  Percent of infected cells that showed µ1 in a dispersed staining pattern. At 
48 h p.i. CV-1 cells were fixed and immunostained using anti-µNS rabbit serum and 
anti-µ1 mAb followed by goat anti-rabbit IgG Alexa 594 conjugated and goat anti-
mouse IgG Alexa 488 conjugated secondary Abs.  100 infected cells were scored per 
sample.  The mean of three samples + standard deviation (S.D.) was used to rank the 
strains. 
 
Strain Genome Sequence % with 
dispersed µ1 
Rank 
 L1 L2 L3 M1 M2 M3 S1 S2 S3 S4  
H14 L L D L L L L D D L 90.0+4 1
EB121 D D L D L D L D D D 89.3+6 2
G16 L L L D L L L D L L 89.0+5 3
H5 D D L L L D L D L D 87.0+5 4
EB113 L L L D L L L L D L 82.3+2 5
EB31 L L L D L L L D D L 82.3+3 5
G2 L D L L L L D L L L 67.0+12 7
EB120 D D D L D L D D L L 64.7+13 8
EB136 D D D L D L D D D D 64.0+5 9
H15 L D D L D D D D D L 63.7+2 10
EB124 D D D D L D D L L L 61.3+7 11
T1L 
(parental) 
L L L L L L L L L L 57.0+2 12
EB62 D D D D D D D L D L 45.0+10 13
EB87 L D L L D L L D L L 44.0+4 14
EB68 L D L L D L L L D D 43.3+3 15
EB138 D L L D D L D D L L 30.0+5 16
T3D-N 
(parental) 
D D D D D D D D D D 25.7+4 17
EB18 D D L D D D L L D L 12.0+1 18
EB118 D D L L D D D D L L 9.3+4 19
EB144 L L L L D D L L D L 7.0+15 20
EB129 D D D D D L D L L D 6.7+7 21
EB28 D D L D D D D L D D 1.7+4 22
138 
Table 5.3.  Statistical analysis of influence of genome segment on distribution of µ1 in 
infected cells.  Mann-Whitney Test was performed on a panel of 22 viruses, listed 
with each genome segment in order of rank based on percent infected cells that 
showed µ1 dispersed in the infected cell. 
 












Table 5.4.  Statistical analysis of influence of genome segments other than M2 (T1L) 
on distribution of µ1 in infected cells. Panel includes only virus strains with T1L-
derived M2 genome segment, except genome segments marked with *.  In order to 
determine statistically value, a larger panel incorporating the virus strains G2, EB136, 
H15, and EB124 were used to analyze the S1 genome segment and derive the second 
p-value listed for L3. 
 
 
Genome Segment 2-tailed p value 
L1 1.0000 
L2 1.0000 








 Table 5.5.  Statistical analysis of influence of genome segments other than M2 (T3D) 
on distribution of µ1 in infected cells. Panel includes only virus strains with T3D-
derived M2 genome segment, except genome segments marked with *.  In order to 
determine statistically value, a larger panel incorporating the virus strains EB62, 
EB68, EB18, EB28 and excluding H15 and EB136 were used to analyze the S1and L3 
genome segment and derive the second p-value listed for those segments. 
 
 
Genome Segment 2 tailed p value 
L1 0.5714 
L2 0.2857 
L3* 0.4857; 0.8333 
M1 0.2500 
M3 0.8857 





pattern of µ1 in infected cells (p<0.05) (Table 5.4). However, when viruses that 
possessed an M2 genome segment derived from T3D parental virus were analyzed, no 
genome segment significantly influenced the distribution of µ1 in infected cells. The 
significance of the S1 genome segment did not carry over to the analysis of the 
reassortant viruses with a T3D derived M2 genome segment (Table 5.5). In this data 
set, as in the first, the S2 genome segment is the closest to being significant; however, 
this may be lost using a larger panel of reassortants with greater diversity at S2. I 
conclude from the analysis of the entire panel of reassortants (Table 5.3), and the 
analysis of reassortant viruses segregated based on the M2 genome segment and /or 
rank in Table 5.3 (see Tables 5.4 and 5.5), that only one genome segment, M2, is 





 Clearly, µ1 has a tendency to localize to ring-like structures in cells infected 
with T3D strain reovirus, whereas µ1 is more likely to be diffusely distributed in the 
cytoplasm of cells infected with T1L (see Fig. 5.1). Analysis of a panel of T1L × Τ3D 
reassortant viruses indicated that the M2 genome segment derived from the T3D 
parent determined the localization of µ1 to ring-like structures in infected cells, 
whereas cells infected with reassortant viruses containing an M2 genome segment 
derived from T1L parent µ1 was more likely to be diffusely distributed (see Table 
5.3). Subsequent studies have shown that expression of µ1 in mammalian cells results 
in both diffuse and ring-like staining patterns, and the ring-like structures were 
identified as lipid droplets (5). 
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Assembly of the inner and outer capsids to form intact virions is poorly 
understood largely because virions or virus particles produced during infection are 
comprised of a fully formed inner and outer capsid. Currently, it is thought that the 
core is assembled first (including λ1, σ2 and λ2) with subsequent addition of µ1:σ3 
complexes to form the outer capsid. This is supported by the ability to form ‘recoated 
core’ particles using baculovirus-expressed recombinant µ1:σ3 and purified cores (4).  
Expression of capsid proteins outside the context of infection results in 
formation of capsid-like structures. Co-expression of inner capsid proteins λ1 and σ2 
forms core-like particles. Furthermore, λ2 and λ3 can be integrated into the core-like 
particles formed by λ1 and σ2. The outer capsid proteins µ1 and σ3 interact to form 
heterohexameric complexes during infection or when expressed in cells. It is thought 
that the µ1 proteins in this heterohexamer interact with an inner capsid protein, λ2, to 
facilitate virion assembly in infected cells (9, 14).  Temperature-sensitive viral mutants 
with lesions that map to the L2 genome segment encoding λ2 are able to form core 
particles but are unable to form whole viroins (14).  
In this study, a panel of 20 reassortant viruses and parental viruses were used 
to determine the genotype that is responsible for the differences in µ1 localization 
during infection. When the entire panel was analyzed, only the M2 genome segment 
encoding µ1 significantly contributed to the phenotypic difference. However, the S1 
genome segment encoding the cell attachment protein σ1 and nonstructural protein 
σ1s, and the S2 genome segment encoding inner capsid protein σ2 had lower p values 
than the other genome segments (see Table 5.3).  
The genome segment S1 encodes two proteins, the structural protein σ1, and 
the nonstructural protein σ1s. σ1s is important to pathogensis as it causes cell cycle 
arrest (7), however it is not necessary for reovirus replication in vitro (12). σ1 is the 
cell attachment protein, and is present as a trimer at the icosahedral vertices of each 
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virion. Beyond forming homotrimers, σ1 is thought to interact with λ2 which is also 
present only at the icosahedral vertices and is thought to anchor σ1 to the virion. A 
potential link between µ1 and σ1 during virion assembly is λ2. L2 does not appear to 
play a role in the µ1 staining pattern as analyzed in this data set, nevertheless, it is not 
excluded from playing a role in assembling µ1 and σ1 onto capsids.    
σ2 is an inner capsid protein which interacts with λ1 and, at the five-fold 
vertices of the capsid, with λ2. λ1 will only form core-like particles if σ2 is present. 
Additionally, co-expression of λ1, σ2, and λ2 results in core-like particles with 
‘turrets’ comprised of λ2 at the five-fold vertices, ressembling the orientation observed 
in whole virions. The µ1:σ3 heterohexamer sits on top of σ2 in the assembled virion 
(14). Thus, σ2 may play an important role in assembly due to interactions with the 
other core proteins λ1 and λ2, and with µ1 in the outer capsid.   
Once the data were separated based on M2 genome segment derivation and  
percent infected cells showing µ1 in/not in a ring-like pattern (Tables 5.4 and 5.5) the 
correlations shifted. In analyzing viruses with a T1L derived M2 genome segment, the 
L3 and S1 genome segments, encoding structural proteins λ1 and σ1 respectively, 
appeared to have a role in the µ1 localization patterns. However, the significance of 
L3 was lost when a larger panel of viruses was analyzed, indicating that the relevance 
in the first analysis was skewed due to the lack of variation (see Table 5.4).  In the 
analysis of viruses with T3D derived M2 genome segments, the other genome 
segments made no significant contributions to the localization of µ1 during infection, 
yet the S2 genome segment, encoding σ2, did have a noticeable lower p value than the 
other genome segments (see Table 5.5). 
Based on this study, M2 is the only genome segment significantly linked to the 
µ1 ring-like staining pattern in infected cells. This staining pattern is associated with 
the M2 genome segment derived from the T3D Nibert strain reovirus. The T1L strain 
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reovirus infection resulted in a µ1 staining pattern that was dispersed in infected cells. 
The S1 genome segment was shown to have a significant influence in the localization 
of µ1 in one of the analysis, and the S2 genome segment had a lower p-value than 
other genome segments in two of the analysis. This data suggest that σ1, σ1s, and σ2 
should be further investigated as having potential roles in µ1 distribution during 
infection and virion assembly. Furthermore, given the proposed interactions of λ2 with 
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There is much to be determined about the mechanism by which µ1-induces 
apoptosis. My studies have shown that µ1 induces cytochrome c release and that 
neither caspase activation nor Bax or Bak are needed for this response. How is 
cytochrome c being released from the mitochondria? Obviously, there needs to be pore 
formation or a perforation of the outer mitochondrial membrane for this to occur. It is 
feasible, given the involvement of µ1 in membrane permeabilization during virus 
entry (see Chapter 1), that µ1 can also directly permeabilize intracellular membranes. 
A study utilizing purified µ1 and isolated mitochondria might provide evidence as to 
the capacity of µ1 to permeabilize the outer mitochondrial membrane. However, as 
with other viral proteins, interactions between µ1 and other mitochondrial proteins, 
such as VDAC and ANT could also result in disruption of the mitochondrial 
membrane, cytochrome c release and subsequent apoptosis induction. 
 It is well-documented that release of cytochrome c is required for activation of 
the intrinsic apoptotic pathway (9). Activation of the extrinsic apoptotic pathway 
usually occurs after ligation of death receptors at the plasma membrane [reviewed in 
(12)]. While there is evidence that caspase-8 can localize to mitochondria (8), and that 
it can be activated in response to ER stress (5), I do not have a sound model or 
explanation for activation of caspase-8 induced by µ1-expression at this time. The 
simplest answer is that, like reovirus-induced apoptosis, µ1 causes release of TRAIL 
or a similar protein which could then bind death receptors, via autocrine interactions, 
resulting in activation of caspase-8. Therefore, an assay to determine if the supernatant 
from µ1-expressing cells contains any apoptotic-inducing factors, including 
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extracellular µ1, would be useful. However, alternative sites of caspase-8 activation 
other than death-receptor ligation at the plasma membrane may need to be explored to 
determine the mechanism by which µ1-expression activates caspase-8. 
 ER-stress responses have not been measured in µ1-expressing cells. However, 
indirect evidence suggests that μ1 might induce an ER response. Coffey et al. showed 
that µ1 localizes to the ER during infection and transfection (3). Additionally, reovirus 
infection has been shown to activate calpain, a calcium-dependent cytosolic protease 
(4). The ER is a major intracellular storage site for Ca2+, therefore, studies into Ca2+ 
flux in response to µ1 expression would be worth exploring. This could be done using 
fluorescent or bioluminescent Ca2+ indicators (11). Evaluation of calpain activity in 
µ1-expressing cells might also be considered; however, the influence of calpain in 
reovirus-induced apoptosis was determined by epifluorescence microscopy using 
DNA and vital dyes and has yet to be linked with a mechanism of apoptosis induction 
during reovirus infection (4). The activation of calpain usually stems from Ca2+ flux 
and can activate pro-caspase-12 (in mice), pro-caspase-3, or Bcl-xL, depending on the 
tissue and cell type (2). Therefore, it would be beneficial to know how calpain is 
influencing the caspase cascade in reovirus-infected cells and relate this to µ1-induced 
apoptosis. 
 I found that the majority of µ1-expressing CHO-S cells released cytochrome c 
from mitochondria. In addition, broad-spectrum caspase inhibitors did not block μ1-
induced release of cytochrome c. Despite this, activation of caspases-8, -9 and -3 
occurred in only 30% to 40% of µ1-expressing cells. One possible explanation for this 
disparity is that inhibitor of apoptosis proteins (IAPs) prevented caspase activation 
despite the release of cytochrome c. Indeed, the percentage of µ1-expressing CHO-K1 
cells showing smac/DIABLO release, which suppresses the IAPs, was lower than that 
of µ1-expressing CHO-K1 cells that released cytochrome c. The percentage of µ1-
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expressing HeLa cells that released smac/DIABLO was ~30%; however, again the 
percentages do not correlate, as HeLa cells do not undergo apoptosis in response to 
µ1-expression (Coffey and Parker, unpublished data). Therefore, it would be 
beneficial to determine the level of XIAP [the IAP shown to be active at physiological 
levels (1)] in µ1-expressing cells as this may help to determine if it plays a role in 
preventing caspase activation downstream of cytochrome c release.  
 Another surprising result that warrants further investigation is my finding that 
inhibition of caspase-8 prevented caspase-3 activation in µ1-expressing cells (see 
Chapter 2). These findings imply that the release of cytochrome c and caspase-9 
activation is not sufficient to activate effector caspases. The kinetics of initiator 
caspase activation would help to determine the order of activation of the intrinsic 
apoptotic pathway and caspase-8 in μ1-expressing cells. In preliminary kinetics 
studies, I found that cytochrome c release occurred in ~30% of µ1-positive cells by 8-
12 hours post-transfection with increased levels of activated caspase-9 occurring from 
12-20 hours post-transfection (data not shown). Caspase-8 could be activated upstream 
of cytochrome c release. However, the percentage of cells with activated caspase-8 or 
-9 was always less than the percentage of cells with released cytochrome c, and at 24 h 
post-transfection the percentage of µ1-expressing cells with released cytochrome c is 
2-2.5 times that of the percentage of µ1-expressing cells with activated initiator 
caspases. Also, the percentage of µ1-expressing cells with released cytochrome c 
increases in response to broad-spectrum caspase inhibitors. Therefore, the mechanism 
leading to cytochrome c release is caspase-independent, as well as Bax and Bak 
independent, and remains to be determined (see Chapters 2 and 3).  
In addition to activating the extrinsic and intrinsic apoptotic pathways, I have 
also found that intracellular µ1 expression also led to permeabilization of the plasma 
membrane. Expression of GFP-µ1 or GFP-φ in cells caused plasma membrane 
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permeabilization as evidenced by the uptake of the membrane-impermeant nucleic 
acid-staining dye TO-PRO®-3 (see Chapter 2). Other evidence that supported the 
hypothesis that the plasma membrane of μ1-expressing cells was permeable included 
my consistent finding of a population of GFP-μ1-expressing cells that did not stain for 
cytochrome c. The mechanism by which this occurs is not known. The one insight into 
this phenomenon I have is that the mechanism to permeabilize the plasma membrane 
appears to be partially dependent on caspase activation, as addition of the broad-
spectrum caspase inhibitor, Q-VD-OPh, prevented the release of cytochrome c from 
the cell of the majority of GFP-µ1 expressing cells. However, Q-VD-OPh was not 
completely protective of the plasma membrane, as GFP-µ1 and GFP-φ expressing 
cells still took up TO-PRO®-3 after treatment with Q-VD-OPh (see Chapter 2).  
Permeabilization of the plasma membrane can be a characteristic of necrotic 
cells (6) or late stage apoptotic cells which have progressed to secondary necrosis (7). 
Late stage apoptotic cells should have a lower refractive index (10) and necrotic cells 
should show osmotic swelling and membrane damage (6), all of which would have an 
impact on the forward and side scatter as measured by flow cytometry (10). However, 
permeabilized GFP-µ1 expressing cells showed similar or slightly increased forward 
scatter when compared to GFP-µ1 expressing cells with intact plasma membranes 
(Chapter 2). Furthermore, side scatter, an estimation of total protein, is similar 
between the intact and permeabilized GFP-µ1 cells (see Chapter 2). It is possible that 
different stages of apoptosis, including secondary necrosis, are responsible for the 
different populations depicted in the histogram of GFP-µ1 expressing plus DMSO-
treated cells.  If this is the case, the similar population in the GFP-µ1expressing plus 
Q-VD-OPh-treated cells may be necrotic cells, yet this population remains 
morphologically similar to the other GFP-µ1 positive cell population such that the 
forward and side scatter of these cells is not drastically different. This data warrants 
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further investigation into the state of µ1-expressing cells treated with broad-spectrum 
caspase inhibitors, as the mechanism by which µ1 induces apoptosis may not be 
blocked and cells may proceed to undergo apoptosis or necrosis in a caspase-
independent manner. However, this is experimentally difficult because the cell 
population would need to be synchronized so that the cells were expressing 
approximately the same amount of µ1 at approximately the same time to determine 
stages of apoptosis and differentiating them from necrosis.  Also, wild-type µ1 can 
only be labeled by permeabilizing the cell, adding to the complexity of designing 
experiments to detect apoptotic stages of these cells. 
Another curious phenomenon was the apparent shift in a population of cells 
from µ1 negative and cytochrome c negative to µ1 positive and cytochrome c positive 
with the addition of Q-VD-OPh. This population was not present in cells transfected 
with a pEGFP-C-M2(1-708); however a GFP-µ1 positive and cytochrome c negative 
population was present. From these results, I hypothesize that the µ1 negative and 
cytochrome c negative population was, initially, µ1 positive. In this sub-population of 
cells, µ1-expression initiated release of cytochrome c from the mitochondria, and 
activated caspases-8, -9, and -3. Activated caspases perhaps then could cleave µ1, 
destroying the epitopes recognized by the antibodies I used, making µ1 undetectable. 
However, if µ1 was fused to GFP, expression could be detected. The data indicates 
that this population was cytochrome c negative and µ1 positive. I am currently 
determining the steady-state levels of µ1 with point mutations at putative caspase 
cleavage sites (Hom and Wisniewski, unpublished data). The putative caspase 
cleavage sites are in the δ fragment, which is the location of the epitopes for the 
monoclonal Abs (13) because they are highly antigenic and associated with the virion, 
they may be epitopes that are also recognized by the anti-T1L virion serum. Cleavage 
of the δ fragment could potentially destroy the epitopes; thereby rendering µ1 
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undetectable by immunostaining, and thus explaining the shift in fluorescence seen by 
incubation with Q-VD-OPh and the detection of GFP-µ1 but not µ1 (see Chapter 2). 
The expression and detection of δ remains largely unaffected because, as previously 
shown, δ does not activate caspases [see Chapter 2 and (3)]. 
In conclusion, I have developed flow cytometric assays that can detect reovirus 
outer caspsid protein µ1 in pCI-M2(1-708) transfected mammalian cells, and have 
optimized protocols to detect activation of the intrinsic and extrinsic apoptotic 
pathways in cells expressing µ1by flow cytometry. My data indicate that the full-
length protein µ1 activates the intrinsic apoptotic pathway, as indicated by cytochrome 
c release from the mitochondrial intermembrane space and caspase-9 activation, and 
the extrinsic apoptotic pathway, as indicated by caspase-8 activation.  Furthermore, I 
found that both pathways must be activated in order for effector caspases to be 
activated in response to µ1 expression. However, caspase activation is not required for 
µ1-induced cytochrome c release, implying that the pathways are independently 
activated. Also, I have provided evidence that the plasma membrane of µ1-expressing 
cells is compromised as cytochrome c was released not only from mitochondria but 
from the cell, and a sub-population of µ1-expressing cells take-up the membrane-
impermeant dye TOPRO-3®.  
In studies utilizing Bax-/-Bak-/- knockout cells, µ1induced cytochrome c release 
whereas other apoptosis inducing agents do not. Thus, I infer that µ1-induced 
cytochrome c release occurs independently of Bax and Bak activation. In addition, I 
found that Bax-/-Bak-/- knockout cells release cytochrome c in response to reovirus 
strain T3D infection. These studies provide evidence that µ1 is a major contributor to 
reovirus-induced apoptosis, and that the mechanism by which reoviruses induce 
apoptosis may be more complex than originally thought. Also, µ1 may be auto-
regulated by several methods, including ubiquitination (Coffey, unpublished data) and 
 154 
cleavage by caspases (see above), allowing for apoptosis induction in a host cell at the 
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